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Abstract 
Calcific aortic valve stenosis (CAVS) is the most severe valvulopathy affecting western world 
population. In the present thesis, in vitro models stimulating metastatic or dystrophic calcification 
in cultured bovine aortic valve interstitial cells (AVICs) were studied. Multivaried stimulations of 
primary cultures of AVICs were performed using inorganic phosphate (Pi) at critical 
concentrations, bacterial endotoxin lipopolysaccharide (LPS), and conditioned medium (CM) 
from cultures of allogeneic LPS-stimulated macrophages. Spectrophotometric estimations 
revealed calcification primarily to depend on elevated Pi levels (≥ 2.0 mM), which were 
comparable with the most elevated normophosphatemic levels and hyperphosphatemic ones. Pi-
dependent effects resulted to be enhanced by adding LPS and CM together but not alone. 
Ultrastructurally, the calcific process consisted in a distinct AVIC degeneration as found for 
actual CAVS, in which the crucial event was a progressive plasmamembrane and organelle 
membrane colliquation that culminated in the generation of an acid-phospholipid-rich material 
outlining dying cells and their remnants and acting as major hydroxyapatite (HA) nucleator. 
AVIC remnants included rounded paracrystalline calcospherulae mirroring those described for 
CAVS. Consistently, Raman micro-spectroscopy applied to calcifying cultured AVICs revealed 
peripheral localization of HA and acidic phospholipids. Formation of calcific nodules also in the 
presence of apoptosis inhibitors and negative immunoreactivity to cleaved caspase 3 and annexin 
V led to exclude apoptosis to occur for calcifying AVICs. Conversely, surviving AVICs were 
found to undergo initial autophagocytosis, as revealed by immunopositivity to marker MAP1-
LC3A, and subsequent derangement as revealed by ultrastructural detection of unusual 
hypertrophy of endoplasmic reticulum correlating with incubation time course and Pi 
concentration. In CAVS-affected valves atherosclerosis-like features were detected, with (i) 
Raman analysis showing colocalization between HA, phospholipids, cholesterol and carotenoids, 
and (ii) parallel electron microscopy revealing the presence of typical intra- and extracellular 
cholesterol crystals. Thus, the effects exerted by native low density lipoproteins in both native 
(nLDL) and aggregated (agLDL) form were explored on cultured AVICs using thin layer 
chromatography (TLC), spectrophotometry, histochemistry and electron microscopy. The 
chromatographically detected amounts of internalized esterified cholesterol differently correlated 
with the spectrophotometrically calcium estimations. Concerning pro-calcific effects, nLDLs and 
agLDLs alone induced mild calcification, whereas their combination with pro-calcific 
Pi+LPS+CM mixture unexpectedly provoked negligible calcification for nLDLs but prominent 
calcification for agLDLs. In conclusion, LDLs are further potential candidates for conditioning 
AVIC-dependent calcification in addition to Pi and other pro-calcific factors. 
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1. INTRODUCTION 
 
 
Calcification is a process that takes place physiologically, in so-called hard tissues, or 
pathologically, in so-called soft tissues. Namely, physiological (orthopic) calcification 
includes endochondral and intramembranous ossification of bones as well as the 
biomineralization of dentin and enamel in the teeth. By contrast, extraskeletal mineralization 
occurs ectopically on respect orthopic one, i.e. various parenchymatous organs, 
cardiovascular structures or tumoral masses. Indeed there are a number of clinical conditions, 
including aging, cancer, diabetes, autoimmune diseases, and other disorders closely correlate 
with calcific processes. 
These pathologies tissue can be related to histogenetic factors or to degenerative 
conditions. In both cases the inherent alterations seems to depend on multifactorial 
phenomena, even occurring according to distinctive condition-dependent and/or tissue-related 
patterns (Anderson H.C., 1983; Bonucci E., 1984; Boskey A.L. et al., 1988). 
This pathological mineralization was reported to consist in an aberrant deposition of 
calcium phosphate salts, including hydroxyapatite (HA), but also calcium oxalates and 
octacalcium phosphate, with detrimental effects (Kim K.M. 1995; Giachelli C.M., 1999).	   
In serum and extracellular fluids calcium (Ca) and inorganic phosphate (Pi) exist in 
metastable equilibrium that is, their levels are too low for spontaneous precipitation but 
sufficient to cause HA formation once crystal nucleation has started (Whyte M.P., 2006). 
Thus, the fundamental step in the process leading to ectopic calcification is the formation of 
HA crystals, which were demonstrated also to bind proteins, lipids, and other biomolecules, 
causing loss of soft tissue flexibility and pliability, encrusting organs and vessels so leading to 
painful outcomes and even lethal ones for patients. 
Ectopic calcification in soft tissues was largely supposed to be a passive, degenerative 
process elicited by the presence of dead and dying cells. During the last decade a great 
number of studies showed that soft tissue calcification is a complex and highly regulated 
phenomenon, with some researchers hypothesizing it even associates with bone-like neo-
formation. In healthy patients, extra-skeletal biomineralization is prevented by a variety of 
inhibitors of mineralization such as inorganic pyrophosphate (PPi), which was reported to be 
a major regulator of vascular calcification during human development (Anderson H.C., 1983; 
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Rutsch F. et al., 2001; Johnson K. et al., 2003). Giachelli and coworkers hypothesized that 
ectopic mineralization results from an imbalance between pro-calcific and anti-calcific 
regulatory molecules (Giachelli C.M., 2005). 
Ectopic calcification can be associated with either abnormal serum levels of calcium 
and/or phosphate or normal ones being called metastatic calcification and dystrophic 
respectively. 
The correlations of metastatic or dystrophic calcification with etiologically associated 
diseases are reported in Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When calcium-phosphorus solubility product (Ca x P) in extracellular fluid surpasses the 
critical value of 60 mg2/dl2 (Vattikuti R. and Towler D.A., 2004), mineral precipitation occurs 
in vital tissues. Initially, metastatic calcification consists in a precipitation of amorphous 
material, whereas crystalline HA is deposited later.  
Hypercalcemia is usually associated with mineral deposits in kidney, lung, and stomach. In 
addition, tunica media of large arteries, endocardial elastic tissue, conjunctiva, and 
periarticular soft tissues are often affected (Whyte M.P., 2006). Other causes leading to 
hypercalcemia are augmented secretion of parathyroid hormone, i.e. hyperparathyroidism 
(Marcocci C. and Cetani F., 2011), malignancies (Lumachi F. et al., 2009) and milk-alkali 
 
TABLE 1: DISORDERS ASSOCIATED WITH ECTOPIC CALCIFICATION  
  
    A. Metastatic calcification  
       I. Hypercalcemia 
 a. Milk-alkali syndrome  
 b. Sarcoidosis 
 c. Hyperparathyroidism  
 d. Renal failure 
       II. Hyperphosphatemia 
 a. Tumoral calcinosis 
 b. Hypoparathyroidism 
 c. Pseudohypoparathyroidism 
 d. Cell lysis after chemotherapy for leukemia  
 e. Renal failure 
    B. Dystrophic calcification 
       I. Calcinosis (universalis or circumscripta) 
 a. Childhood dermatomyositis  
 b. Scleroderma 
 c. Systemic lupus erythematosus 
       II. Post-traumatic event 	  
                                                                        adapted from Whyte M.P. (2006)  
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syndrome, due to massive ingestion of calcium and absorbable basic salts (Abreo K. et al., 
1993). Finally, it was assumed to depend on elevated levels of vitamin D3, as in sarcoidosis 
(Baughman R.P. et al., 2013). 
Conversely a condition of hyperphosphatemia, with elevated serum levels of phosphorus 
occurs in idiopathic hypoparathyroidism or pseudohypoparathyroidism (Maeda S.S. et al., 
2006). It can be also associated with tumoral calcinosis because of releasing of 
intracellularcellular phosphate from cells lysed by chemotherapeutic drugs (Farrow E.G. et 
al., 2011; Slavin R.E. et al., 2012). Moreover, abnormal mineral imbalance associated with 
hyperphosphatemia, is commonly observed in glomerulosclerosis resulting from diabetes, as 
well as in severe chronic renal disease (CRD),	  an advanced renal failure, commonly called 
end-stage renal disease (ESRD), that requires dialysis or kidney transplantation. As a 
consequence of CRD, secondary hyperparathyroidism implies an increase of parathyroid 
hormone levels, with resulting changes in plasma vitamin D3, calcium, phosphorus, and an 
increase of their Ca x P product (Liebermann M. et al., 2013). Patients with CRD are often 
subjected to advanced atherosclerosis and a high cardiovascular mortality rate. CRD severity 
and complexity causes a prominent metabolic dysfunction, leading to accelerated, extensive 
calcification in intimal and medial layers of arterial walls.  
An example of a calcifying disorder in hyperphosphatemic conditions is metastatic 
calcinosis occurring in the skin and implying the formation of nodular deposits of calcium and 
phosphate, overall in periarticular sites. Hyperphosphatemia can be also associated with 
vascular calcification, as in vascular calciphylaxis.  
In absence of a systemic mineral imbalance, dystrophic calcification occurs in soft tissues 
as a result of injury, aging, disease (Giachelli C.M., 1999) or metabolic alterations, such as 
hypercholesterolemia or hyperglycemia, which causes osmotic and oxidative stresses 
(Vattikuti R. and Towler D.A., 2004).  
Of the soft tissues that potentially undergo ectopic calcification, blood vessels, heart 
valves, and the kidney, are the most susceptible to develop this pathology (Anderson H.C. and 
Morris D.C., 1993).  
 
1.1 VASCULAR CALCIFICATION 
Growing evidence exists that vascular calcification is on the verge of an epidemic disease 
concerning the westernized societies (Towler D.A., 2008), being shared risk factors aging, 
renal failure, and type II diabetes mellitus (T2DM) and shared hypertriglyceridemia, 
increased serum low density lipoproteins (LDL), decreased serum high-density lipoproteins 
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(HDL), obesity, and hypertension (O'Brien K.D. et al., 1996; Olsson M. et al., 1999; Pohle K. 
et al., 2001).  
In dystrophic calcification, vascular mineral deposition was described to occur according 
to three histoanatomic variants consisting in cardiac valve calcification (tricuspid valves, 
mitral valves, pulmonary valves and aortic valves), calcification of arterial tunica intima 
(intimal calcification) or calcification of arterial tunica media (medial calcification) (Vattikuti 
R. and Towler D.A., 2004; Lau W.L. and Ix J.H., 2013). In all these three cases the 
mineralization process shared different but overlapping mechanisms. Intimal calcification 
affects atherosclerotic plaques in the context of the disease called “atherosclerosis”, whereas 
medial calcification is also called  “arteriosclerosis” (Table 2). 
 
 
TABLE 2: MACROVASCULAR CALCIFICATION: A HISTOANATOMIC VIEW 
 
 Cardiac valve calcification    Interstitial cell activation/inflammation Senile calcific aortic sclerosis 
   Dystrophic calcium deposition Bicuspid aortic valve calcification 
   T cells, macrophages, interstitial adipocytes,  Bioprosthetic valve calcification 
   and myofibroblasts 
   Osteogenesis, intramembranous  
   bone formation 
   Rare cartilage metaplasia/calcified cartilage,  
   infrequent endochondral bone formation 
   Marrow formation with hematopoiesis  
   visualized in advanced disease 
 Atherosclerotic calcification   Cellular necrosis and debris Atherosclerosis 
   Evolution of fibro-fatty plaque Hypercholesterolemia 
   Calcium deposition with lipoproteins,  Similar histology in calcifying 
   cellular lipid debris fibrotic myocardial infarct 
   Macrophages, T cells, endothelial dysfunction,  
   platelet and myofibroblast activation 
   Cartilage metaplasia/calcified cartilage,  
   endochondral bone formation 
   Marrow formation with hematopoiesis  
   visualized in advanced disease 
      
 Medial artery calcification   Adventitial activation/inflammation Type 2, type 1 diabetes 
   Macrophages, T cells, myofibroblasts,  End-stage renal disease 
   adipocytes,medial VSMCs and CVCs 
   Matrix vesicles, with osteogenesis resembling  
   intramembranous bone formation  
   No cartilage formation 
 
adapted from Vattikuti R. and Towler D.A. (2004) 
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The present thesis primarily focuses on ectopic mineralization and underlying mechanisms 
at level of aortic valve leaflets affected by calcific aortic valve stenosis (CAVS).  
 
1.1.1 AORTIC VALVE CALCIFICATION 
CAVS affects 2.8% of adults over 75 years old is by at different extents (Nkomo V.T. et 
al., 2006), being the second most common indication for cardiac surgery (Roberts W.C. and 
Ko J.M., 2005), which is associated with an 80% risk of progression to heart failure, valve 
replacement or death within five years (Otto C.M. et al., 1997). In addition, surgical cusp 
replacement is still the sole therapeutic approach to the most severe form of CAVS, to date.  
Even more worrying, the incidence and prevalence of valve disease is increasing 
worldwide due to the world population increasing age. Yacoub	  M.H. and Takkenberg J.J.M. 
(2005) reported that in the next forty years, the world population will increase as well as the 
proportion of over 60 aged people. Thus, the annual number of patients requiring heart valve 
replacement is estimated to triple from approximately 290,000 in 2003, to over 850,000 by 
2050. Notably, the largest increase in the world population will be seen in third-world 
countries, in which not all patients will have access to this treatment. Strategies to address this 
global problem could have an important impact.  
The risk factors shared by CAVS and atherosclerosis, hypertension, older age, male 
gender, smoking, hypercholesterolemia and diabetes have been reported (Stewart B.F. et al., 
1997; Pohle K. et al., 2001; Peltier M. et al., 2003; Freeman R.V. and Otto C.M., 2005; 
Messika-Zeitoun D. et al., 2007). All Likely, these factors increase the incidence of aortic 
stenosis contributing to leaflet damage including endothelial defects and dysfunction (Mohler 
E.R. 3rd, 2004). 
However, although risk factors and downstream mediators appear similar for these 
diseases, about 50% of patients with valve calcification are exempt from clinically significant 
atherosclerosis (Mazzone A. et al., 2007; Qian J. et al., 2010).  
The semilunar aortic valve is a pentalayered anatomical entity that opens and closes almost 
100,000 times a day permitting unidirectional forward blood flow maintaining sufficient 
strength and durability to tolerate repetitive mechanical stress over a lifetime.  
Valve pliability and elasticity are guaranteed by the distinct texture of the constitutive 
extracellular matrix (ECM). A monolayer of endothelial cells envelopes the aortic and 
ventricular surfaces of the valve leaflet, forming two of its five layers together with a weak 
subendothelial, intimal-like sheet, whereas the inner valve interstitial cells (VICs) are 
represented by a mixed population of fibroblasts, myofibroblasts and smooth muscle cells 
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(SMCs) (Della Rocca F. et al., 2000). VICs populate the ECM, which is composed by three 
highly organized sheets, named (i) tunica fibrosa, at the aortic side, (ii) tunica spongiosa, 
intermediate, and (iii) tunica ventricularis, at the ventricular side. A strictly controlled 
balance between synthesis and degradation of ECM components is controlled by VICs, which 
mediate constant repair and remodelling. Of the major components, collagen fibers are more 
abundant in the fibrosa, glycosoaminoglycans (GAGs) in the spongiosa, and elastin fibers in 
the ventricularis. 
The early morphological stage of aortic valve disease is named aortic valve sclerosis, 
consisting in a mild valve thickening without obstruction of blood flow. Aortic sclerosis is 
present in almost 25% of adults 65 years of age, being associated with a 50% increase risk of 
cardiovascular events (Otto C.M. et al., 1999). 
Otherwise the later pathological stage, known as aortic valve stenosis, is a degenerative 
condition in which a massive calcification of the leaflets (Fig. 1.1) impairs theirs motion and 
can lead to obstruction of the blood outflow, with subsequent left ventricular hypertrophy, 
heart failure, and sudden death.  
Macroscopically, sclerosis is characterized by an increased leaflet thickness and stiffening, 
whereas stenosis implies additional leaflet commissural fusion and subsequent calcification 
(Stewart B.F. et al., 1997). Progression of aortic valve disease is showed in Figure 1.1. The 
calcific process begins at level of the fibrosa, along the leaflet adherent margin. With a slowly 
gradual progression, the calcific nodules spread toward the fibrosa invading the entire cusp.  
 
Figure 1.1. The identified cardiovascular risk factors involved in the development of aortic valve disease 
from sclerosis to CAVS (Rajamannan N.M. et al., 2011). 
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In the past, calcification process was thought to be unmodifiable, because the gradual wear 
and tear of the leaflets with passive calcium deposition (Mönckeberg J.C., 1904). Now, 
histopathologic and clinical data suggest that CAVS is an active pathobiological process of 
valve modification similar to atherosclerosis because of lipoprotein deposition (O'Brien K.D. 
et al., 1996; Olsson M. et al., 1999), chronic inflammation, and calcium deposition as HA 
(Otto C.M. et al., 1994; Rajamannan N.M. et al., 2003).  
 
1.1.2 ATHEROSCLEROTIC (INTIMAL) CALCIFICATION 
Atherosclerosis occurs in aorta and in large elastic arteries and consists in intimal lipid 
deposits forming plaques of variable size that lead to eccentric lumen obliteration.  
The atherosclerotic plaque stability depends on the formation of a thick fibrous cap, which 
envelops a small lipid core (Doherty T.M. and Detrano R.C., 1994). 5 to 10µm long, needle-
shaped HA mineral crystals appear in early lesions in the third decade of life. It was 
previously believed that calcification occurs only in the most advanced, end-stage plaque in 
the elderly. Calcifications near the luminal surface may be subjected to erosion. However, Lin 
and colleagues found that calcification does not seem to increase plaque vulnerability when 
testing in vitro the mechanical response of a calcified plaque model to fluid stress (Lin T.C. et 
al., 2006). 
As mentioned above, risk factors of atherosclerosis are hypercholesterolemia, increased 
low-density lipoprotein cholesterol, increased lipoproteins, increased triglycerides, decreased 
high-density lipoprotein cholesterol, male gender, cigarette smoking, hypertension and 
diabetes. 
Atherosclerotic calcification is initially characterized by cellular necrosis, inflammation, 
and lipoprotein and phospholipid complexes (Demer L.L., 2002). Calcium deposition occurs 
at level of lipoproteins as well as lipid complexes, derived from cellular membranes, located 
within the atherosclerotic plaques. Oxidized lipid products provide several signals that recruit 
and activate macrophages and T cells. Whether atherosclerotic calcification is cause or 
consequence of cardiovascular disease is still controversial.  
Atherosclerotic calcium deposits could stiffen the aorta and affect plaque stability (Sage 
A.P. et al., 2010) as well as atherosclerosis could induce cellular osteogenic differentiation in 
vascular smooth muscle cells (VSMCs) implying calcification of neoformed bone matrix 
(Böstrom K. et al., 1993).  
Indeed, calcium deposits cause compliance mismatch at the interface of the rigid mineral 
with the more distensible artery wall tissue. Under mechanical stress, this interface has a 
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greater risk for mechanical failure, resulting in a break of the fibrous cap  (Richardson P.D. et 
al., 1989; Farb A. et al., 1996). Plaque rupture, or ulceration, is believed to cause most 
myocardial infarction and stroke as well as thrombotic phenomena. Calcium deposits 
dramatically redistribute stress in plaque, reducing it in some regions and increasing it in 
others (Hoshino T. et al., 2009) with the exposition to rupture risk depending on the anatomic 
orientation of the calcium deposits on respect to the plaque and associated necrotic core.  
In arterial walls, calcification positively correlates with atherosclerotic plaque burden 
(Beadenkopf W.G. et al., 1964) and increasing in risk of (i) myocardial infarction, (ii) 
ischemic episodes in peripheral vascular system, and (iii) rupure after angioplasty. 
 
1.1.3 ARTERIOSCLEROTIC (MEDIAL) CALCIFICATION 
Medial artery calcification, also known as Mönckeberg’s sclerosis, is the circumferential, 
contiguous, and confluent calcification afflicting the muscular medial layer of arterial walls, 
occurring independently from atherosclerosis. This type of calcification is common in elderly 
patients and linearly afflicts increasing aged population (Reid J.D and Andersen M.E., 1993; 
Elliott R.J. and McGrath L.T., 1994; Tohno Y. et al., 1996), but also normal young patients 
with no overt metabolic disease (Mori H. et al., 1992; Top C. et al., 2002). 
Medial calcification has been linked to disorders characterized by generalized metabolic 
alterations, as well as derangements concerning electrolytes or pH. Correlations are reported 
with hypervitaminosis D (Mallick N.P. and Berlyne G.M., 1968), hyperphosphatemia, as in 
ESRD (Foley R.N. et al., 1998), and overall diabetes mellitus (Everhart J.E. et al., 1988; 
Lehto S. et al., 1996; Chantelau E. et al., 1997; Edmonds M.E., 2000) and its complications 
such as autonomic neuropathy (Edmonds M.E. et al., 1992; Gentile S. et al., 1990).  
Furthermore, the medial artery calcification is an emerging important predictor of (i) 
diabetes severity and duration, (ii) lower extremity amputation, and (iii) cardiovascular 
mortality risk (Lehto S. et al., 1996).  
Medial calcification can occur frequently in aorta wall, but it is typically encountered in 
arteries having low propensity to develop atherosclerosis, such as abdominal visceral arteries, 
arteries of thyroid and breast, and arteries supplying the extremities (reviewed by Doherty 
T.M. et al., 2004).  
Medial calcification has been reported rarely to occur in coronary arteries, whose 
calcification is associated with atherosclerotic plaque (Nakamura S. et al., 2009). 
In small- and medium-sized vessels, medial calcification is known as calcific uremic 
arteriolopathy (CUA), or calciphylaxis, and occurs when the physiological calcium phosphate 
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solubility threshold is elevated (Qunibi W.Y. et al., 2002). CUA causes ischemic and 
ulcerating tissue necrosis of dermis, subcutaneous tissue, muscles, and internal organs 
(visceral calciphylaxis) (reviewed by Ng A.T. and Peng D.H., 2011).  
Aortic stiffness is an important consequence of medial calcification, and calcification has 
the greatest effect on aortic rigidity (Demer L.L., 1991) resulting in hypertension, left 
ventricular hypertrophy, ischemia, heart failure, lower limb amputation, and death (Shao J.S. 
et al., 2010). 
A comparison between intimal and medial calcification is showed in Figure 1.2. 
 
 
Figure 1.2. Atherosclerotic vs medial arterial calcification. Both types stiffen arterial 
conduit vessels. The eccentric remodeling of atherosclerotic calcification also reduces 
lumen diameter, and predisposes to acute thrombosis. (Thompson B. and Towler D.A. 
2012). 
 
 
1.2 CALCIFICATION MECHANISMS IN CARDIOVASCULAR SYSTEM 
An unsolved problem concerning the calcific processes is the identification of the starting 
point of HA nucleation. Mineralization results from physicochemical and biochemical 
processes eliciting HA crystal deposition in topic areas in the ECM. 
In ectopic calcification a primary role was ascribed to the cells, similarly to physiological 
mineralization occurring in bone and pre-calcific cartilage, in which an involvement exists of 
matrix vesicles (MVs) resulting from budding of 50-to-200 nm sized cytoplasmic bodies by 
osteoblasts and hypertrophic chondrocytes, respectively (Bonucci E., 1967; Anderson H.C., 
1967; Bonucci E., 1971; Wuthier R.E., 1982). 
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Polarized release of MVs was reported to occur at level of (i) chondrocyte edges during 
biomineralization in growth plate cartilage (Anderson H.C., 1969; Cecil R.N.A. and Anderson 
H.C. 1978), (ii) osteoid-facing surfaces of osteoblasts in newly formed bone (Anderson H.C. 
et al., 1973; Palumbo C., 1986), and (iii) apical surfaces of odontoblasts in the tooth pre-
dentine (Bernard G.W., 1972; Eisenmann D.R. and Glick P.L., 1972). Usually, increasing 
electron density of MVs, because of amorphous CaPO4 mineral pre-deposition, precedes HA 
crystal formation.  
The polarized vesiculation from these types of cells, as well as the specific molecule 
composition of MVs versus the mother cell, denotes a highly organized process involving a 
great number of molecules. For example, in the membranes of MVs lipid bilayer is unusually 
enriched by acidic phospholipids (Wuthier R.E., 1976). In addition, their outer surfaces show 
prominent concentration of alkaline phosphatase (ALP), which promotes calcification by 
reducing pyrophosphate (PPi) levels (Rachow J.W. and Ryan L.M., 1988; Hessle L. et al., 
2002), and annexins, in particular, annexin II, V and VI. Annexins are Ca2+ and phospholipid 
binding integral proteins, which can form calcium channels through MV membranes, 
stimulating calcium uptake (Wuthier R.E. et al., 1992; Kirsh T. and Wuthier R.E., 1994; 
Kirsh T. et al., 1997). Otherwise, the Pi enters via a type III Na+-dependent phosphate 
transporter (PiT), to form apatite within MVs (Li X. and Giachelli C.M., 2004). Additionally, 
Pi is delivered by	   ALP, that degrades PPi and adenosine triphosphate (ATP), commonly 
known as mineralization inhibitors (Anderson H.C. et al., 2004). 
Anderson and Sajdera reported that the initial calcification occurs at level of the inner 
membrane of the vesicle wall, being the early crystals of HA detected in that location 
(Anderson H.C. and Sajdera S.W., 1976; Anderson H.C., 1980). 
Essentially, physiological mineralization is a biphasic phenomenon (Anderson H.C., 
1995). During the first phase, intravesicular calcium concentration increases due to its affinity 
for acidic phospholipids and Ca-binding proteins of the vesicle membrane interior. 
Phosphatases, for example ALP, act on ester phosphate of matrix vesicle fluid producing a 
local increase in PO4 in the vicinity of vesicle membrane. The intravesicular ionic product Ca 
x P is raised, resulting in initial deposition of calcium-phosphate at membrane inner side. 
When sufficient Ca2+ and PO43- have accumulated within the MVs, CaPO4 mineral begins to 
precipitate in non-crystalline form. Amorphous CaPO4 is converted to octacalcium phosphate, 
whose crystals are then transformed into the highly insoluble HA (Anderson H.C., 1969; Wu 
L.N. et al., 1993). Accumulation and growth of intravesicular crystals leads to their 
penetration of the MV membrane and the subsequent exposition to the extravesicular 
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environment. In addition, hydrolytic action of phospholipases (Wuthier R.E. et al., 1978) and 
proteases of MVs (Dean D.D. et al., 1992) result in MV breakdown. 
The second phase consists in epitaxial mineral propagation, because the extravesicular 
fluid is supersaturated of calcium, enabling further crystal nucleation to take place (Anderson 
H.C. et al., 2004).  
Then new self-nucleated crystals of HA accumulate forming spherical clusters at MV 
surfaces.  
Cells and cell-derived products (CDP) as well as matrix vesicles-like structures, were 
considered initiators of calcific process of both native and bioprosthetic valves, whereas 
collagen is considered to play a secondary role, linked to the subsequent propagation of 
calcific phenomena in the ECM (Kim K.M. and Huang S., 1971; Kim K.M., 1976; Schoen 
F.J. et al., 1985; Valente M. et al., 1985; Schoen F.J. et al., 1986; Schoen F.J. and Levy R.J., 
1992; Girardot M.N. et al., 1995; Ortolani F. et al., 2002a; Ortolani F. et al., 2002b). These 
final pro-calcific products, called calcospherulae or spherulites, appear as target-like bodies 
being often coated by needle-like apatite crystals oriented perpendicularly to their membrane 
(Fig. Valente). These cell-derived pseudocrystalline structures were found not only in native 
valves (Kim K.M., 1976) but also in bioprosthetic valves (Valente M. et al., 1985) and in in 
vitro calcifying aortic VICs (Bonetti A. et al., 2012). 
Alternatively, the initial phase of intracellular calcification was also assumed to occur at 
nuclear envelope and/or mitochondria of dead or dying cells, with initial HA accumulation 
(Schoen F.J. et al., 1985; Girardot M.N. et al., 1995).  
Ortolani and colleagues shed light on the events underlying valve mineralization 
modifying classical pre-embedding histochemical reactions for electron microscopy (i) 
phthalocyanin cuprolinic blue (CuB) or (ii) diaminotriphenyilmethane dye malachite green 
combined with (iii) post-embedding silver salt staining. Thus, parallel preservation and 
visualization of acidic mixtures of phospholipid-containing proteo-lipidic material and HA 
removal with unmasking of calcific sites were achieved (Ortolani F. et al., 2002a; Ortolani F. 
et al., 2002b; Ortolani F. et al., 2003; Ortolani F. et al., 2007). 
Namely, in in vivo subdermal model of valve calcification, cell involvement was found to 
occur throughout the release of lipids by degenerating organules and their release into 
cytoplasm as phthalocyanin positive material (PPM) and its subsequent peculiar outcropping 
at cell edges as phthalocyanin positive layers (PPLs) lining cells and cell-derived matrix-
vesicle-like bodies. In addition, PPLs were found to represent the major HA crystal nucleators 
Moreover, PPL-like material was observed to spread outside mineralized cells enveloping 
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collagen fibrils and elastin fibres so also triggering ECM calcification. 
Additional precipitation of HA crystals was reported to occur at level of the gap zones of 
collagen fibrils as later extra-vesicular event (Arsenault, A. L. et al., 1991) as well as early 
MV-independent calcific process (Glimcher M.J., 1981).   
The increase of acidic phospholipids in the membranes of pro-calcific MVs led to the 
hypothesis of direct involvement of phosphatidylserine (PS), phosphatidylinositol (PI) and 
phosphatidic acid (PA) (Wuthier R.E., 1973; Vogel J.J. and Boyan-Salyers B.D., 1976; 
Wuthier R.E., 1976). Such an involvement was also assessed by Odutuga and colleagues, in 
the same years (Odutuga A.A et al., 1975). They demonstrated that these phospholipids 
extracted from both hard and soft tissues are able to precipitate HA from calcium-phosphate 
metastable solutions in in vitro conditions.  
Since 1970s, a considerable insight was the discovery of specific complexes isolated from 
mineralized or mineralizing tissues (Boskey A.L. and Posner A.S., 1976; Boskey A.L. et al., 
1977; Wuthier R.E. and Gore S.T., 1977) each formed by calcium, acidic phospholipids and 
phosphate (Ca-PL-PO3). 
These complexes were not believed to be composed by apatite crystals adsorbed on the 
surface of phospholipids, but a distinct material (an intermediate), which could lead initial 
nucleation, and growth of apatite crystals by orientating suitably the bound calcium and 
phosphate ions. 
In detail, the enzymatic deletion of serine or inositol suggests that calcium bind to both the 
phosphate and carboxyl groups for PS and phosphate and hydroxyl groups for PI. 
Thus Ca-PL-PO3 complexes were assumed to act as calcification nucleator by promoting 
HA formation. Moreover, an influence on calcification by magnesium, HCO3, citrate, 
enzymes, proteins, proteoglycans and other factors was found.  
The high content of acidic phospholipids in MV membrane not only allow them to bind 
Ca2+, but also facilitate binding with calcium-dependent annexins (Wuthier R.E. et al., 1992; 
Kirsh T. et al., 1997). 
As above mentioned, the role of acidic phospholipids was ultrastructurally confirmed by 
Ortolani and colleagues in subdermally implanted porcine aortic valve leaflets (Ortolani F. et 
al., 2003). 
Thus the Ca-PL-PO3 complexes could interact with a lot of different molecules, such as 
ALP, proteolipids, cholesterol, etc. suggesting the existence of more composite nucleators 
(named “nucleational core complex”), as biochemically shown in hypertrophic cartilage 
(Boyan B.D. and Boskey A.L., 1984; Wu L.N. et al., 1991; Wu L.N. et al., 1993; Kirsch T. et 
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al., 1994; Wu L.N. et al., 1996). The involvement of a great number of these molecules was 
also assessed in aortic valves and bioprosthetic ones, supporting the idea that different types 
of mineralization could share common mechanisms of action	  (Kim K.M. and Huang S., 1971; 
Kim K.M., 1976; Levy R.J. et al., 1980; Levy R.J. et al., 1983b; Maranto A.R. and Schoen 
F.J., 1988; Levy R.J et al., 1991; Jorge-Herrero E. et al., 1991; Jorge-Herrero E. et al., 1994). 
Furthermore, acidic membrane phospholipids are present at greater extents in necrotic 
areas, being associated with CDPs and calcospherulae, thereby eliciting calcification of 
necrotic tissues. In particular, these structures are abundant in aortic atherosclerotic lesions 
(Kim K.M., 1976; Tanimura A. et al., 1983). Ca-PL-PO3 complexes were identified in human 
atheroslerotic aortas, suggesting that calcification mechanism may occur in a series of 
surgical specimens affected by pathological calcification besides in bone and calcifying 
cartilage (Dmitrovsky E. & Boskey A.L., 1985; Boskey A.L. et al., 1988). These findings 
suggested a possible correlation between these cell debris and MVs acting in physiologically 
calcifying tissues.  
The two structures are not identical, but it is likely that both guarantee a favorable 
environment for mineralization. Interestingly, these pro-calcific bodies could represent a link 
between physiological and dystrophic calcification (Anderson H.C., 1983). 
 
1.3 MOLECULAR DETERMINANTS The	  etiopathogenesis	  of	  cardiovascular	  tissue	  is	  the	  result	  of	  active	  processes	  such	  as	  lipid	   accumulation	   and/or	   alteration,	   inflammatory	   responses,	   loss	   of	   inhibition	   cell	  osteogenetic	   differentiation	   and	   cell	   death.	   It is still debated which factors represent the 
major triggers of the calcific process. Besides, mineralization seems to depend by the 
balanced action of promoters and inhibitors. 	  
 
1.3.1 INORGANIC PHOSPHATE 
Growing evidence indicates that Pi is an important driver of vascular calcification affecting 
VSMCs and VICs. 
Pi is fundamental in most cellular processes, including energy metabolism, signal 
transduction, storage and translation of genetic information and maintenance of lipid 
membrane structure. The majority of phosphate in humans (85%) is located in bone, in which 
it is complexed with calcium under form of HA. Normal phosphate serum levels are 
conventionally comprised within a range between a minimum of 0.8 to 1.45 mM (Tonelli M. 
et al., 2005; Osuka S. and Razzaque M.S, 2012) up to a maximum of 2.0 to 2.1 mM (Jono S. 
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et al., 2000; Rodriguez-Benot A. et al., 2005). Disturbances outside this range, resulting in 
hypo- and hyperphosphatemia, are known to be clinically relevant. Several observational 
studies showed a link between cardiovascular morbidity and mortality and higher serum 
phosphate levels (Tonelli M. et al., 2005; Dhingra R., et al., 2007; Foley R.N. et al., 2009; 
Larsson T.E. et al., 2010). Furthermore, even relatively small elevations of Pi in the high 
normophosphatemic range have been correlated with increased risk of cardiovascular 
diseases, including ectopic calcification (Tonelli M. et al., 2005; Ellam T.J. and Chico T.J., 
2012; Osuka S. and Razzaque M.S., 2012). 
Phosphate levels are predominantly maintained by fibroblast growth factor (FGF)-23, 
which is secreted by osteocytes and reduces calcitriol levels (Fukumoto S., 2005). 
Additionally, FGF-23 acts on kidneys causing phosphaturia, and therefore reduces serum 
phosphate levels (Nabeshima Y., 2008).  
Another active component of calcification is the functional sodium-dependent phosphate 
transport system, including phosphate transporter PiT1 (Jono S. et al., 2000; Li X. et al., 
2006; Villa-Bellosta R. et al., 2007). Moreover, Giachelli and colleagues demonstrated that Pi 
induces VSMCs calcification in vitro by a direct mechanism involving Pit-1 (Jono S. et al., 
2000). 
Another enzyme implied in phosphate axis is a metalloenzyme known as phosphate-
monoester phosphohydrolase, commonly named alkaline phosphatase, which was 
demonstrated to have two roles in promoting mineralization. First, it supplies substrate for 
HA mineral deposition inducing Pi releasing from organic phosphate conjugates. The second 
role involves the hydrolysis of PPi (Lomashvili K.A. et al., 2008) thereby increasing Pi 
concentration and in parallel decreasing its anti-calcific role. 
Additionally, calcium uptake was found inversely to correlate with ALP activity (Genge 
B.R. et al., 1988), the decline of which was found to depend on loss of metal ions Zn2+ and 
Mg2+ rather than the action of a specific protease. 
Wuthier and colleagues hypothesized an additional role of ALP, which might facilitate the 
attachment of MV to collagen fibrils, inducing the formation of nucleation complexes (Wu 
L.N. et al., 1996). 
Being ALP an enzyme working in bone tissue, a great number of researchers correlated an 
increase of ALP activity with the priming of osteogenetic differentiation by vascular cells in 
the context of various models of vascular tissue calcification (Chen N.X. et al., 2002; 
Giachelli C.M. et al., 2005; Mathieu P. et al., 2005; Osman L. et al., 2007). 
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1.3.2 INFLAMMATORY MEDIATORS 
Inflammation is a prominent feature in aortic valve calcification, being present in both 
early and advanced aortic valvular lesions (Olsson M. et al., 1994; Otto C.M. et al., 1994). 
Cellular inflammatory infiltrates are not common in normal aortic valves. In fact, T-
lymphocytes were absent and only rare macrophages were found to be scattered within the 
interstitium of normal valve leaflets, whereas inflammatory infiltrate composed of 
macrophages and T cells characterized early valvular lesions (Otto C.M. et al., 1994). These 
activated inflammatory cells lying in the subendothelium and in the fibrosa are reported to 
induce a chronic inflammation with release of cytokines and enzymes such as interleukins IL- 
2 (Olsson M. et al., 1994) and IL-1𝛽 (Kaden J.J. et al., 2003), transforming growth factor beta 
1 (TGF-β1) (Jian B. et al., 2003), tumor necrosis factor alpha (TNF-α) (Kaden J.J. et al., 
2005b), and matrix metalloproteinases (MMPs) (Edep M.E. et al., 2000), which contribute to 
ECM remodeling, inflammatory activation of myofibroblasts which, in turn, seem to develop 
an osteoblast-like phenotype, with subsequent calcification. 
Interestingly, Toll-like receptors (TLR) and the complement system seem to be also 
involved in the pathogenesis of CAVS (Helske S. et al., 2008; Meng X. et al., 2008), as well 
as in-vitro stimulation of TLR can promote an osteogenic transdifferentiation by VICs. 
Epidemiologic data indicated that bacterial endocarditis leads to calcification in aortic 
valves (Otto C.M. et al., 1999). Babu and colleagues postulated that osteoblastic phenotype 
acquirement by VICs take place in response to circulating bacterial products, thereby 
contributing to the pathogenesis of CAVS (Babu A.N. et al., 2008). 
 
1.3.2.1 TRANSFORMING GROWTH FACTOR-BETA (TGF-β) 
The TGF-β proteins superfamily comprises cytokines and peptide growth factors that 
regulate biological functions in many systems including cardiovascular one. TGF-β1 is 
present in human calcific aortic stenotic cusps. Interestingly, in sheep aortic VIC cultures 
TGF-β1 was found to promote calcification through mechanisms involving apoptosis (Jian B. 
et al., 2003). 
Otherwise, TGF-β blocking antibody prevented nodule formation. Consistently, increased 
expression of TGF-β in the ECM correlated with increased ALP activity in both in vitro and 
ex vivo conditions (Clark-Greuel J.N. et al., 2007).  
In addition, TGF-β treatments were reported to induce tissue remodelling during 
calcification of human aortic valves by increasing the active form of MMP-2 and MMP-9 pro-
enzyme, in in-vitro experiments, as well as the expression of MMP-9 and tissue inhibitor of 
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MMPs (TIMPs) in ex vivo specimens (Clark-Greuel J.N. et al., 2007). In VSMC cultures rich 
in phosphate, neutralization of TGF-β does not inhibit calcification, indicating that this 
cytokine is not directly involved in calcium deposition (Wang N. et al., 2010). 
Interestingly, exogenous addition of TGF-β to the wound was found to modulate VIC 
response to injury by increasing VIC activation and proliferation, wound closure rate, and 
stress fibers expression (Liu A.C. and Gotlieb A.I., 2008). 
 
1.3.2.2 TUMOR NECROSIS FACTOR-ALPHA (TNF-α) 
Tumor necrosis factor-α (TNF-α) is a pleiotropic cytokine secreted by several types of 
cells, including activated macrophages, T lymphocytes, SMCs, and fibroblasts. It is involved 
in acute and/or chronic inflammation as a response to many factors such as oxidized LDLs 
(Jovinge S. et al., 1996), damaged ECM (Alexandraki K. et al., 2006) and bacterial infection 
(Guzik T.J. et al., 2006).  
TNF-α involvement in vascular calcification was firstly reported by Tintut and colleagues 
who treated bovine aortic SMCs with TNF-α also demonstrating this cytokine to elicit 
downstream upregulation of ALP (Tintut Y. et al., 2000). Further studies identified TNF-α in 
both human and mouse atherosclerotic lesions and calcified aortic valves (Frostergård J. et al., 
1999; Boesten L.S. et al., 2005; Yu Z. et al., 2011). 
Concerning aortic valve calcification, TNF-α was found to act as an inducer of ECM 
remodelling (Kaden J.J. et al., 2005a), cell proliferation and differentiation (Kaden J.J. et al., 
2005b), and calcification (Yu Z. et al., 2011).	   
 
1.3.2.3 RANK/OPG/RANKL SYSTEM 
The transmembrane protein receptor activator of nuclear factor κB (RANK), its ligand 
(RANKL), and its decoy receptor osteoprotegerin (OPG) constitute a cytokine system of the 
TNF superfamily, which is involved in the regulation of bone resorption and vascular 
calcification (Bucay N. et al., 1998;	  Kiechl S. et al., 2006; Panizo S. et al., 2009). 
OPG is a soluble receptor that binds to RANKL, thereby inhibiting the interaction of 
RANKL and RANK, once expressed by a variety of tissues and cell types including SMCs 
and endothelial cells, whereas RANKL and RANK are not expressed in vascular tissue under 
physiologic conditions (Simonet W.S. et al., 1997). Deletion of the OPG gene leads to severe 
calcification of aorta and renal arteries, associated with the expression of RANKL and RANK 
in the calcified areas, suggesting RANKL to promote vascular calcification, with OPG 
playing a protective role (Min H. et al., 2000). Consistently, OPG-null mice resulted to 
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develop arterial calcification. An involvement of OPG in mineralization was also 
demonstrated in VSMC calcification, where it seems to exert inhibitory effects on 
calcification (Bucay N. et al., 1998). Otherwise RANKL has reported to promote extracellular 
mineralization in VSMC cultures via a BMP4-dependent mechanism (Panizo S. et al., 2009). 
Mouse studies have shown that the RANKL-RANK pathway is the gatekeeper of 
osteoclast differentiation and activation (Nakagawa N. et al., 1998).  
Kaden and colleagues firstly demonstrated the role of RANKL/OPG pathway in aortic 
valve myofibroblasts, showing that RANKL promotes matrix calcification in in vitro 
mineralizing conditions. In addition, increasing in ALP activity and synthesis of osteocalcin 
was found; hence this system was hypothesized to induce an osteogenetic phenotype in the 
cultured cells (Kaden J.J. et al., 2003). 
 
1.3.3 CALCIFIC INHIBITORS 
A lot of findings have showed that most tissues, including heart valves and blood vessels, 
normally express inhibitors of mineralization. The lack of these molecules, named “loss of 
inhibition”, indicate that calcium phosphate deposition starts when pro-calcifying conditions 
overwhelm the anticalcifying capacity of tissues, leading to calcification. 
 
1.3.3.1 PYROPHOSPHATE 
In humans, a pathologic example of the importance of calcifying inhibitor mechanism is 
heritable deficiency of the small molecule PPi, which leads to idiopathic infantile arterial 
calcification (Rutsch F. et al., 2001).  
PPi is the anionic form of pyrophosphoric acid and resulted to be regulated by the opposite 
activity of two enzymes. Of these, ectonucleotide pyrophosphatase/phosphodiesterase 1 
(NPP1) catalyses its synthesis hydrolysing ATP, whereas ALP catalyses its hydrolysis 
(Rachow J.W. and Ryan L.M., 1988; Hessle L. et al., 2002; Harmey D. et al., 2004).  
Additionally, PPi is released with the involvement of ANK, a protein that shuttles 
intracellular PPi to the extracellular milieu (Harmey D. et al., 2004). 
PPi is present in almost all ECMs, and several studies have shown that PPi is a potent 
inhibitor of medial vascular calcification in vitro conditions (Lomashvili K.A. et al., 2004; 
Villa-Bellosta R. et al., 2011) and in vivo (Schibler D. et al., 1968). It performs the inhibitory 
activity by binding nascent HA crystals and preventing further incorporation of Pi ions into 
these crystals (Hessle L. et al., 2002; Harmey D. et al., 2004). Additionally, it acts as inhibitor 
of calcific phenotype acquirement by VSMCs (Johnson K. et al., 2005) occurring in 
Introduction 
	   21 
normopyrophosphatemic conditions (Fleisch H. et al., 1966).  
In animal models, vascular calcification was induced via lowering of PPi levels, as it 
occurs in mice carrying the ANK mutation or in NPP1-null mice, there latter exhibiting 
cartilage-specific gene expression changes in their SMCs (Johnson K. et al., 2005).  
Villa-Bellosta and Sorribas highlighted that PPi is able to completely inhibit all HA 
deposition under physiological conditions, but it can inhibit only one third of calcium 
deposition during hyperphosphatemia (Villa-Bellosta R. and Sorribas V. 2011). 
 
1.3.3.2 OSTEOPONTIN 
Osteopontin (OPN) is an acidic, multifunctional protein with a primary structure including 
several structural domains such as an arginine-glycine-aspartate (RGD) adhesive domain and 
a calcium-binding domain, which is rich in aspartic acid. In addition, OPN can be highly 
phosphorylated on serine and threonine residues, a structural feature which is required for 
mineral inhibitory effects (Jono S. et al., 2000).  
The combination of electronegative-glutamic and aspartic acid residues, putative specific 
calcium-binding motifs and sites acting as substrate for serine/threonine kinases endows OPN 
with ability to bind prominent Ca2+amounts (50 moles of calcium per 1 mole of OPN) (Chen 
Y. et al., 1992). OPN was discovered in mineralized tissues such as bones and teeth, but has a 
wide tissue distribution and was also identified in calcified vascular lesions (Giachelli C.M. et 
al., 1993). Although OPN is not present in normal arteries, Fitzpatrick and colleagues as well 
as Giachelli and co-workers reported OPN to be abundant at calcification sites of human 
atherosclerotic plaques and in calcific aortic valves (Fitzpatrick L.A. et al., 1994; O’Brien 
K.D. et al., 1995).  
The role of OPN in vascular calcification has been investigated using both in vitro and in 
vivo approaches (Steitz S.A. et al., 2002). In first case, OPN was demonstrated to inhibit the 
calcification of SMC, cultured with elevated phosphate with a dose-dependent fashion. OPN 
was intimately associated with growing apatite crystals, suggesting physical inhibition of the 
crystal growth to represent one of the mechanisms for inhibition (Jono S. et al., 2000).  
In in vivo experiments using OPN double null mice showed earlier and more severe 
mineralization of vessels was found in comparison with matrix Gla protein deficient mice 
(Speer M.Y. et al., 2002). Another in vivo approach was applied by Steitz and co-workers, 
consisting in implantation of glutaraldehyde-fixed porcine aortic valves into OPN null mice. 
They showed a very greater degree of calcification compared with valves implanted into wild 
type mice (Steitz S.A. et al., 2002). Furthermore, OPN not only inhibited HA deposition but 
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also caused its regression. Such a regression correlated with the carbonic anhydrase II (CAII) 
expression in the macrophages surrounding the implants and led to acidification of the 
implants. 
Steitz and colleagues proposed that OPN secreted by stromal or inflammatory cells at sites 
of ectopic mineralization binds bioapatite so representing a recognition site or providing a 
concentration gradient for macrophage and giant cells leading to their topical accumulation 
with parallel up-regulation of CAII via cell surface OPN receptors. This leads to increased 
proton efflux, acidification of the local microenvironment, and dissolution of the bioapatite 
(Steitz S.A. et al. 2002). Thus, OPN may function not only as a physical inhibitor of apatite 
crystal growth, but also may promote mineral regressive mechanisms by controlling the 
cellular gene expression patterns that favour mineral resorption. 
In immunohistochemical study on calcium-binding proteins in failed bioprosthetic porcine 
valves retrieved from humans, OPN was found to be associated with the calcifications areas 
exclusively, whereas bone markers such as osteocalcin, bone sialoprotein and osteonectin 
were unreactive (Shen M. et al., 1997). 
In failed bioprosthetic porcine valves retrieved from humans, OPN was 
immunohistochemically detected with the calcifications areas exclusively, whereas no 
immunohistochemical positivity resulted for other bone proteins such as osteocalcin, bone 
sialoprotein and osteonectin (Shen M. et al., 1997). 
 
1.3.3.3 FETUIN-A 
Fetuin-A, a hepatocyte derived serum glycoprotein, is the most abundant non-collagenic 
protein in bone tissue (Termine J.D. et al., 1981). Clinically, low serum levels of fetuin-A 
affect patients with moderate to severe chronic kidney disease, especially dialysis patients. 
This cysteine protease inhibitor belongs to the cystatin superfamily of calcium binding 
proteins being characterized by a cystatin-like domain containing a lot of acidic aspartic and 
glutamic acid side chains and acts sequestrating calcium phosphates (Heiss A. et al., 2003).   
Fetuin-A binds calcium phosphate and calcium carbonate, but not calcium alone, with high 
affinity (Schinke T. et al., 1996)	   and plays the additional role of binding directly to 
transforming growth factor beta (TGF-β1, TGF-β2) and bone morphogenic protein (BMP2, 
BMP4, BMP6) and also inactivating them (Binkert C. et al, 1999).  
In contrast with OPN, fetuin-A only inhibits de novo formation of calcium phosphate 
rather than to dissolve preformed mineral, thus preventing the growth and aggregation of 
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calcific nuclei as well as subsequent formation of larger entities and ultimately mineral 
precipitation (Rochette C.N. 2009). 
Fetuin-A is considered an opsonizing serum protein because of  its capability of shielding 
spontaneously formed small mineral complexes of calcium-phosphate, making colloidal, 
nanoscopic particles which should be otherwise insoluble. Jahnen-Dechent and colleagues 
named these fetuin-calcium-phosphate complex as "calciprotein particles" (CCPs) and 
hypothesized that fetuin mediates their cellular uptake and clearing by phagocytosis (Jahnen-
Dechent W. et al., 2008; Jahnen-Dechent W. et al., 2011).  
Fetuin-A was shown to inhibit VSMC calcification experimentally induced by elevated 
concentrations of extracellular mineral ions (Reynolds J.L. et al., 2004; Reynolds J.L. et al., 
2005). Fetuin-A enhanced uptake by phagocytosis with vesicular recycling of fetuin-mineral 
complexes reducing both apoptosis and calcification. In addition, subsequent fetuin-A release 
from apoptotic and viable VSMCs abrogated extracellular calcium phosphate precipitation. 
Fetuin-A was thought to be a mineral chaperone mediating the uptake of mineral from the 
extracellular space and general circulation, thereby contributing in prevention from of ectopic 
calcification at level of plasma and tissue fluids (Westenfeld R. et al., 2009).  
In addition to its anti-calcific properties effects, fetuin-A has found to play a role in 
diabetes, via inhibition of insulin receptor autophosphorylation and tyrosine kinase activity in 
in vitro and in vivo conditions, with the involvement of the acidic amino acids clustered 
within the cystatin-like domain 1 (briefly reviewed by Burke A.P. et al., 2007; Mathews S.T. 
et al., 2006). 
 
1.3.3.4 MATRIX GLA PROTEIN 
Matrix γ-carboxyglutamic acid (Gla) protein (MGP) is considered an inhibitor of 
cardiovascular calcification and its function depends on vitamin K-dependent γ-carboxylation 
of glutamate residues, a process inhibited by warfarin. 
MGP is thought to be a potent regulator of calcium deposition via (i) direct binding 
calcium ions and nascent crystals, (ii) inhibition of bone morphogenetic proteins, and (iii) 
regulation of apoptosis (Proudfoot D. and Shanahan C.M., 2006). MGPs reported to be also 
associated to both physiological (Hauschka P.V. et al., 1975) and pathological calcification 
(Lian J.B. et al., 1976; Levy R.J. et al., 1979), including human aortic valves (Levy R.J. et al., 
1980).  
Their involvement in calcification was also found for porcine aortic valves implanted in rat 
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subcutis (Fishbein M.C. et al., 1982) as well as their inhibitory role in both arterial 
calcification in MGP null mice (Luo G. et al., 1997; Murshed, M. et al., 2004) and arterial 
and valvular calcification after warfarin intake (Price P.A. et al., 1998; Schurgers L.J. et al., 
2004). 
Osteocalcin (OCN) is the major Gla-containing bone protein, which was found to be 
involved in the regulation of bone mineralization. OCN is not normally expressed in vascular 
cells, but its expression by human SMCs is induced in calcific arterial walls and in in vitro 
pro-calcific environment (Jono S. et al., 2000). It	  has been also found in explanted human 
calcified cardiac valves (Levy et al., 1983a) and in porcine glutaraldehyde-preserved 
bioprostheses after implantation in bovine aortic roots (Levy et al., 1983b) or in rat subcutis 
(Levy et al., 1983c). Although the existing correlation between this vitamin-K-dependent 
protein amount and tissue calcium levels, lacking of calcification after vitamin K-antagonist 
therapy suggested no significant OCN involvement in this pathogenesis, so being regarded as 
an useful monitoring factor of calcification (Levy R.J. et al., 1983c).	  By contrast, no positivity 
to OCN was revealed by immonostaining with polyclonal antibodies against calcium-binding 
proteins, in failed bioprosthetic porcine valves retrieved from humans (Shen M. et al., 1997).	  
In vitro studies (Boskey A.L. et al., 1985) OCN was found to inhibit the growth of seeded 
HA, whereas it had some effects on the initial crystallization of HA in the presence of Ca-PL-
PO3 complexes, albeit without direct interactions. In addition, OCN resulted to differ from the 
other Gla-containing proteins, because of its high affinity for both HA crystals and acidic 
phospholipids. 
 
1.3.4 LIPID FACTORS 
Aortic valve degeneration mechanism is similar to that underlying atherosclerosis, with 
lipids playing a fundamental role in calcific process induction. In fact, epidemiologic data 
indicated a link between dyslipidaemia (high levels of LDLs, triglycerides, and low levels of 
high-density lipoproteins) and development of CAVS, as in metabolic syndrome (Briand M. 
et al., 2006; Goldbarg S.H. et al., 2007; Rabuş M.B. et al., 2009).  
Histological and immunohistochemical studies showed that early valvular lesions are 
characterized by a subendothelial thickening of the leaflet tunica fibrosa with presence of 
intra- and extracellular lipids and microscopical calcification (Otto C.M. et al., 1994). One of 
the main causes of these injuries is the damage of the endothelial layer overlying the valve 
due to elevated shear stress, with its increased permeability and initial infiltration and 
accumulation of circulating lipids. Subsequent endothelium destruction elicits an increasing 
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influx of atherogenic LDLs, followed by invasion into the valve of inflammatory cells, such 
as monocytes and T-lymphocytes. LDLs accumulate in valvular interstitial tissue with 
inflammatory consequences that could drive to calcification (O’Brien K.D. et al., 1996).  
Peculiar LDL structure allows nonpolar lipids to be transported by blood stream as soluble 
molecules. LDL particles are formed by a hydrophobic core containing esterified cholesterol 
and triglycerides and shielded by a phospholipid monolayer including unesterified 
cholesterol, and apolipoprotein apoB-100 (Fig. 1.3).  
 
 
Figure 1.3. Three-dimensional reconstruction of LDL particle using electron cryomicroscopy. Image left shows 
an outside view of LDL and the disposition of apo B-100 (yellow cable) on external shield. The cut-away view of 
the particle (right) shows the internal organization of cholesteryl ester moieties. Phospholipid head groups, 
cholesteryl ester and triglycerides are displayed as cyan, magenta, and blue balls respectively (adapted from Ren 
G. et al., 2009). 
 
Overall, LDL particles contain about 1,600 esterified cholesterol molecules, 700 
phospholipid molecules, 600 unesterified cholesterol molecules, and 170 triglyceride 
molecules (Esterbauer H. et al., 1992; Oörni K. et al., 2000). Phosphatidylcholine (PC) and 
sphingomyelin (SM), represent about 70% (500 molecules) and 30% (200 molecules) of LDL 
phospholipids. The peripheral molecules specifically interact to each other forming distinct 
domains on the LDL surface: there is evidence that apoB-100 is irreversibly associated with 
the PC molecules, whereas cholesterol interacts preferentially with SM (Sommer A. et al., 
1992; Mattjus P. and Slotte J.P., 1996; Murphy H.C. et al., 1997).  
At least in part, lipoprotein deposition within the subintima is mediated by accumulated 
ECM proteoglycans, including biglycans and decorins, with apolipoprotein positively charged 
amino acids binding negatively charged glycosaminoglycan side chains of proteoglycans 
(O’Brien K.D. et al., 1995; Olsson U. et al., 1997).  
LDLs trapped in the subendothelial spaces undergo modifications such as oxidation, 
aggregation and fusion (Olsson M. et al., 1999). Oxidized lipoproteins (oxLDL) were firstly 
detected in human and rabbit atherosclerotic lesions (Ylä-Herttuala S. et al., 1989). These 
modified lipoproteins are highly cytotoxic and capable to promote inflammatory responses 
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and subsequent mineralization (Demer L.L., 2002). In an in vitro study, a role of oxLDL in 
stimulation of osteoblastic differentiation of vascular fibroblasts was suggested (Parhami F. et 
al., 1997). In an in vivo study, a single injection of human LDL resulted in their accumulation 
within rat arterial walls, with oxidative modification within six hours (Calara F. et al., 1998). 
The presence of oxidized LDL was associated with activation of transcription factor nuclear 
factor κ B (NFκB) in the endothelium, as well as with endothelial expression of intercellular 
adhesion molecule-1 (ICAM-1). Even mild oxidative modification alters LDL particle 
structure making them capable to aggregate (Hoff H.F. and O'Neil J., 1991). 
oxLDLs are present in stenotic valves (Olsson M. et al., 1999), with high content 
correlating with severe sclerosis, greater leukocyte infiltration, and expression of 
inflammatory cytokines, such as TNF-α (Mohty D. et al., 2008). Moreover, in vitro studies 
showed oxidized cholesterol to stimulate calcified nodule formation by valve fibroblasts 
(Mohler E.R. 3rd, et al., 1999) 
High contents of valve oxLDL seem to correlate with high serum levels of so called "small 
dense LDL", which represents a subclass of LDL with distinct atherogenic properties 
(Packard C. et al., 2000; Rizzo M. and Berneis K., 2006), due to their characteristics, such as 
(i) small size, that permits to easily penetrate into the arterial wall, (ii) high affinity for 
proteoglycans of the arterial wall which results in a prolonged residence time in the 
subendothelial space (Anber V. et al., 1996), and (iii) lacking in vitamin E making them 
highly susceptible to oxidization (Goulinet S. and Chapman M.J., 1997; Tribble D.L. et al., 
2001). 
Valvular endothelial dysfunction or injury also leads to increased expression of adhesion 
molecules VCAM-1, ICAM-1, and E-selectin with associated recruitment of inflammatory 
cells (Müller A.M. et al., 2000). 
In vivo studies on hypercholesterolemic rabbits (Rajamannan N.M. et al., 2002; Zeng Z. et 
al., 2007) as well as in vitro studies on myofibroblasts (Rajamannan N.M. et al., 2002) 
showed extracellular aggregated and fused lipid particles to accumulate in the stenotic aortic 
valves and revealed aortic valve calcification to be mediated in part by the lipoprotein 
receptor-like protein 5 (Lrp5)/β-catenin pathway. 
Modifications of the surface structure of LDL particles can result in loss of their stability 
leading to LDL aggregation and subsequent fusion. Aggregation of LDL implies their 
surfaces to touch each other without particle merging as well as size changing. More 
extensive particle modifications lead to energetic stabilization resulting in their fusion 
(Pentikäinen M.O. et al., 1996).  
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Aggregated LDL (agLDL) isolated from atherosclerotic lesions were demonstrated to be 
10- to 50-fold enriched in ceramide, which is the lipolytic product of sphingomyelinase 
resulted from the hydrolysis of SM (Schissel S.L. et al., 1996). Furthermore, secretory 
sphingomyelinase and secretory phospholipase A2 were found to play roles in the 
modification of LDL during arterial intima atherogenesis. Indeed, sphingomyelinase induced 
both aggregation and fusion, whereas only LDL aggregation was caused by phospholipase A2 
(Öörni K. et al., 1998; Schissel S.L. et al., 1998).  
Aggregation of normal LDLs by vortexing was found to convert them into a form that was 
readily uptaken by mouse peritoneal macrophages through a LDL-receptor-dependent 
mechanism (Khoo J.C. et al., 1988).  
In in vivo and in vitro experiments, macrophages were shown to internalize variously 
modified LDLs including agLDLs, becoming foam cells, whereas lipid accumulation into 
VSMCs was restricted to agLDLs and according to a peculiar pattern of internalization 
(Llorente-Cortés V. et al., 1998).  
Compared with native LDL (nLDL), which are taken up through endocytic LDL receptor 
(LDLr), agLDL are taken up with different pathway, involving LDL-related protein 1 (LRP1) 
(Llorente-Cortés V. et al., 2000; Llorente-Cortés V. et al., 2002a; Llorente-Cortés V. et al., 
2002b). LRP1-mediated selective uptake of agLDL induced high intracellular cholesteryl 
ester accumulation in lipid droplets surrounded by lipid-binding protein adipophilin 
contributing to the transformation of human VSMCs into foam cells (Llorente-Cortés V. et 
al., 2006). 
 
1.4 CALCIFICATION AND CELL DEATH 
Ectopic calcification is associated with cell death. In particular, apoptosis-derived or 
autophagocytosis-derived bodies are reported as HA-nucleating structures, so playing the 
same pro-calcific role of matrix vesicles in mineralizing cartilage and bone (Kim K.M., 1995; 
Lee Y.S. and Chou Y.Y., 1998; Proudfoot D. et al., 2000; Jian B. et al., 2003; Somers P. et 
al., 2006; Clarke M.C.H et al., 2008).	   
Apoptotic processes were detected to occur around calcific loci interspersed throughout (i) 
the media of arteries affected by Mönckeberg’s sclerosis, (ii) neointimal atherosclerotic 
plaques, and (iii) the fibrosa of aortic valves affected by calcific stenosis (Lee Y.S. and Chou 
Y.Y., 1998; Schoppet M. et al., 2004).	  Pro-apoptotic protein containing MV-like remnants 
were found in advanced carotid atherosclerotic plaques (Kockx M.M., et al., 1998). 
Moreover, a role of apoptosis was suggested in in vitro calcification because of the 
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identification of apoptotic markers in mineralized nodules of calcified VSMCs (Proudfoot D. 
et al., 2000). 
Sheep AVIC cultures stimulated with TGFβ-1 developed calcified, ALP-enriched nodules 
also containing apoptotic cells (Jian B. et al., 2003). However, although apoptosis has been 
implicated in the formation of calcified cell nodules in vitro (Proudfoot D. et al., 2000), 
administration of an apoptosis inhibitor to cultured cells did not affect the formation of 
calcific nodules (Jian B. et al., 2003). 
Macroautophagocytosis (here referred as autophagy) was reported to be involved in 
degenerative aortic valve disease (Somers P. et al., 2006). Autophagy is described as 
surviving process for recycling cellular components such as long-lived proteins and damaged 
organelles by sequestering them within double-membrane vesicles called autophagosomes, 
which fuse with primary lysosomes with subsequent degradation. 
It can be stimulated by stress, such as starvation, hormones and by cellular damage. If cell 
damage is irreversible, too cell components are enzymatically digested, resulting in cell death 
without release of toxic substances so avoiding inflammation in the surrounding tissue. Thus, 
autophagy can be also referred as a primarily caspase-independent cell death mechanism 
executed by lysosomal enzymes triggered when caspase-dependent routes fails as a response 
to cytotoxic agents such as oxLDL (Olsson M. et al., 1999).  
After treatment with oxysterol, in cultured human VSMCs myelin figure formation was 
observed as well as processing of microtubule-associated protein (MAP) 1A/1B-light chain 3 
(LC3) (Martinet W. et al., 2004).  This is a ubiquitous soluble protein, which represents an 
important autophagic marker. In fact, during autophagy, cytosolic form of LC3 (LC3-I) is 
conjugated to phosphatidylethanolamine to form LC3-phosphatidylethanolamine conjugate 
(LC3-II), which is recruited to autophagosomal membranes (Klionsky D.J. et al., 2012). Since 
in the same study great amounts of ubiquitinated cells were detected in calcified aortic valves, 
compared to apoptotic cells, it was suggested that autophagic cell death rather than apoptosis 
might play a role in the release of matrix vesicles in degenerative aortic valves. 
In contrast, shared degeneration steps other than those characterizing both apoptosis and 
autophagy were found to affect calcifying AVICs in three conditions: (i) actual valvular 
stenosis (Ortolani F. et al., 2010; unpublished results), (ii) in vivo experimental calcification 
in xenogenically implanted aortic valve leaflets (Ortolani F. et al., 2002a; Ortolani F. et al., 
2002b; Ortolani F. et al., 2003; Ortolani F. et al., 2007), and (iii) in vitro calcification in 
AVIC cultures after addition of different pro-calcific agents (Ortolani F. et al., 2010; Bonetti 
A. et al., 2012). 
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Such a degenerative steps consisted in (i) initial formation of cytoplasmic vacuolization, 
lysosome-like dense bodies, cytoplasmic protrusions and general increase of membrane 
components; (ii) overall dissolution of plasmalemmas, nuclear envelopes and organule 
membranes; (iii) increasing cytoplasm electrondensity due to the accumulation of dark 
amorphous PPM because of its positivity to histochemical reaction with the phthalocyanin 
CuB; (iv) centrifugal exudation of this material, giving rise to the formation of the marginal 
PPL; (v) PPL budding and pinching off generating thick walled CDPs and CDP-derived 
paracrystalline by-products named calcospherulae. The final cell derived particles were 
someway identifiable as MV-like bodies due to their size and shared capacity to nucleate HA 
crystals. 
 
1.5 IN VIVO PRO-CALCIFIC MODELS 
Animal model are useful systems in elucidating the complex molecular and cellular 
mechanisms underlying cardiovascular pathologies including CAVS in the native 
hemodynamic and biochemical environment. Besides understanding pathophysiologic factors 
and disease natural progression, the reliable tests of the effects exerted by various therapeutic 
agents are provided.   
Some species such as swine can develop spontaneous vascular and valvular atherosclerotic 
lesions (Skold B.H. and Getty R., 1961) in contrast with others, such as rabbits and mice. In 
vivo studies of CAVS focused on animals, in which the pathologic process is elcited or 
accelerated by (i) exposure to known risk factors such as high-cholesterol, high-fat, or high-
carbohydrate diets (Nievelstein-Post P. et al., 1994; Rajamannan N.M. et al., 2002; Drolet 
M.C. et al., 2003; Cimini M. et al., 2005; Zeng Z. et al., 2007), (ii) knockout crucial genes 
such as apolipoprotein E, LDL receptor, or MGP (Luo G. et al., 1997; Tanaka K. et al., 2005; 
Weiss R.M. et al., 2006; Aikawa E. et al., 2007), (iii) or combination of both injuries (Drolet 
M.C. et al., 2006). 
Several studies concerning calcification of implanted bioprosthetic valves were developed. 
Circulatory in vivo models are most predictive of the success of a new valve designs or anti-
calcification studies, however they are expensive and rate of calcification is slow.  
Alternatively, an interesting approach was a model consisting in xenogenic implantations 
of porcine aortic valve into rat subdermal tissue. With this economical model, calcification 
occurs rapidly exhibiting histologic and chemical features that resemble those in failed 
clinical specimens (Levy R.J. et al., 1983c; Schoen F.J. et al., 1985).  
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1.6 IN VITRO PRO-CALCIFIC MODELS 
In the attempt to clarify the mechanisms underlying cardiovascular tissue mineralization, 
in the last decade several in vitro models have been developed simulating metastatic 
calcification by using elevated levels (>2.0 mM) of either organic phosphate (Mathieu P. et 
al., 2005) or Pi (Jono S. et al., 2000; Steitz S.A. et al., 2001; Giachelli C.M. et al., 2005). In 
addition, attention was focused on inflammation involvement by treating cells with either 
bacterial endotoxin lipopolysaccharide (LPS) (Babu A.N. et al., 2008) or inflammatory 
cytokines, such as TGF-β (Watson K.E. et al., 1994; Jian B. et al., 2003; Clark-Greuel J.N. et 
al., 2007), TNF-α (Tintut Y. et al., 2000), or IL-1β (Kaden J.J. et al., 2003). Moreover, an 
intriguing approach that mimics in vivo conditions was the treatment of so called calcifying 
VSMC subset with conditioned medium from cultures of heterogenic macrophages stimulated 
with LPS (Tintut Y. et al., 2002), likely containing pro-inflammatory cytokines, as confirmed 
by subsequent studies (Xu et al., 2007; Wu L.N. et al., 2009). Pro-calcific effects on cultured 
AVICs were also achieved by co-stimulations with high Pi concentrations plus inflammatory 
stimuli, such as TNF-α (Kaden J.J. et al., 2005b) or LPS (Rattazzi M. et al., 2008). 
Finally, in vitro models were developed simulating either severe dystrophic calcification 
(Ortolani F. et al., 2010) or metastatic one (Bonetti A. et al., 2012), using elevated Pi alone 
and/or combined with LPS and pro-inflammatory mediators derived from allogenic cultures 
of LPS-stimulated macrophages. 
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2. AIMS OF THE THESIS 
 
 
 
Calcific aortic valve stenosis (CAVS) takes place in the great field of ectopic soft tissue 
calcification representing the third cause of cardiovascular disease in the western world 
population. Although CAVS has been largely investigated in the last decades, the causes and 
mechanisms are still not clear. It is still debated whether the calcific processes start at the 
intracellular level or matrix level. Semilunar aortic valves are particularly prone to 
mineralization with surgical valve transplantation still representing the sole therapeutic 
approach to this pathology, to date. In the present work, CAVS was studied applying different 
experimental techniques on cultured aortic valve interstitial cells (AVICs). 
In order to study the calcific process, the present thesis has been designed as follows: 
1) elucidation of the specific role played by pro-calcific agents alone, or combined as 
revealed by histochemical, ultrastructural and spectrophotometrical investigations on 
cultured calcific AVICs using in vitro models mimicking both metastatic and dystrophic 
calcification. Results concerning metastatic calcification have been published (Bonetti A. 
et al., 2012) (Appendix); 
2) identification of cell responses to pro-calcific and pro-inflammatory agents correlating 
with a distinct pro-calcific cell death; 
3) ultrastructural characterization of actual CAVS on calcified aortic valves explanted from 
patients; 
4) identification and localization of distinct chemical components characterizing CAVS-
affected human aortic valves and cultured AVICs, using Raman microspectroscopic 
analysis; 
5) study of the effects exerted by native- and aggregated low density lipoproteins (LDLs) on 
AVICs, using an in in vitro model mimicking pro-atherosclerotic environment, combined 
or not with pro-calcific one.  
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3. MATERIALS AND METHODS 
 
 
3.1 ISOLATION AND CULTURE OF AVICs 
Primary cultures of AVICs were obtained by enzymatic digestion of aortic valve leaflets 
isolated from hearts of slaughtered healthy bovines (age 1⁄4 15 months), as previously 
described by Rattazzi and colleagues (Rattazzi M. et al., 2008). Namely, excised aortic roots 
were placed in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) plus 1% 
penicillin/streptomycin and 1 mg/ml amphotericin B kept cool in ice. Then, aortic valve 
leaflets were isolated, depleted of endothelial cells by gentle surface scraping, and minced 
into 2-3 mm3 pieces, which were digested with type-I collagenase (125 U/ml; Sigma), elastase 
(8 U/ml; Sigma), and soybean trypsin inhibitor (0.375 mg/ml; Sigma) for 30 min at +37°C. 
After digestion, the pieces were transferred into tissue culture Petri dishes (Greiner) and 
cultured in DMEM plus 20% Foetal Bovine Serum (FBS; Gibco), 1% L-glutamine, and 1% 
penicillin/streptomycin for 7-10 days. Once drawn from the digested pieces, AVICs were 
cultured in complete DMEM as above until pre-confluent state and expanded up to 10 folds. 
Cells from passages 4 to 6 were used. Light microscopy monitoring was made using an 
Olympus IX70 inverted microscope. 
 
3.2 SAMPLING OF HUMAN AORTIC VALVES 
Native, tricuspid aortic valves were surgically explanted from patients (n = 4; mean age = 
78.3 years) subjected to cardiac valve replacement at the Cardiothoracic Surgery Unit of the 
University-Hospital Enterprise of Udine. All aortic valves were affected by severe, non-
rheumatic stenosis as diagnosed by the evaluation of pre-operative clinical and 
echocardiographic parameters (valve area < 1cm2; middle transvalvular gradient > 65mmHg). 
After explantation, aortic valves were transiently maintained in sterile physiological solution 
to allow (i) macroscopic examination, which revealed the presence of large calcific nodules 
protruding at cusp aortic surface, and (ii) excision of cusps, each of which was then 
subdivided into two emicusps such that one was destined to cooling and the other to electron 
microscopy processing. Emi-cusps were cooled by dipping into 2-methylbutane liquid kept 
cool in liquid nitrogen. 
Materials and Methods 	  
	   33 
3.3 CONDITIONED MEDIUM FROM RAW264.7 MACROPHAGES 
Murine RAW264.7 macrophages were plated on tissue culture flasks (Falcon) and cultured 
in DMEM supplemented with 10% FBS, 1% L-glutamine, and 1% penicillin/ streptomycin. 
At pre-confluence, RAW cells (passage 4) were stimulated with LPS (100 ng/ml; Sigma) for 
1 h at +37°C, rinsed twice with DMEM plus 10% FBS, and additionally cultured in complete 
DMEM for 12 hs achieving macrophage degranulation. After culture medium collection and 
centrifugation, supernatant was 0.22-µm-filtered, added with 1% polymyxin B (BioChemika) 
to neutralize residual LPS, and stored at -20°C until use. 
 
3.4 CONDITIONED MEDIUM FROM BOVINE FRESH MACROPHAGES 
Fresh lympho/monocytes were collected by Ficoll® (1:2; GE Healthcare) density gradient 
centrifugation of peripheral blood from healthy bovines and then plated on tissue culture 
flasks and maintained in complete DMEM, supplemented with 10% FBS, 1% L-glutamine, 
and 1% penicillin/ streptomycin, overnight. After lymphocyte removing by rinsing with 
DMEM plus 10% FBS, monocytes were cultured in complete DMEM for 3 days to promote 
cell differentiation. These monocytes/macrophages were stimulated with LPS (100 ng/ml) for 
1 h at +37°C, rinsed twice with DMEM plus 10% FBS, and additionally cultured in complete 
DMEM for 12 hs achieving macrophage degranulation. After medium collection and 
centrifugation, supernatant was 0.22-µm-filtered, added with 1% polymyxin B, and stored at -
20°C until use. 
 
3.5 LDL ISOLATION AND AGGREGATION 
Human LDLs (1.019 to 1.063 g/mL) were obtained from pooled sera of 
normocholesterolemic volunteers and isolated by sequential ultracentrifugation. LDLs were 
dialyzed three times against 200 volumes of 150 mmol/L NaCl, 1 mmol/L EDTA, and 20 
mmol/L Tris-HCl, pH 7.4, overnight and once against 150 mmol/L NaCl. LDL protein 
concentration was determined by the bicinchoninic acid (BCA) method and cholesterol 
concentration by a commercial kit (Pierce).  
Aggregated LDLs (agLDLs) were prepared by vortexing in PBS at room temperature. 
agLDLs (precipitable fraction) were separated from the non-aggregated LDLs (non-
precipitable fraction) and their percentage was calculated by measuring the fraction of protein 
recovered in the pellet obtained after centrifugation at 10 000 g for 10 minutes.  
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3.6 AVIC TREATMENTS 
At pre-confluence, AVICs seeded on 35 mm culture plates (Greiner) were cultured in 
DMEM plus 10% FBS, 1% L-glutamine, and 1% penicillin/streptomycin (i) alone (control-
cultures) or supplemented with: (ii) 20% (v/v) murine RAW264.7 macrophage conditioned 
medium (mCM-cultures); (iii) 20% (v/v) bovine macrophage conditioned medium (bCM-
cultures); (iv) 100 ng/ml LPS (LPS-cultures); (v) 3.0 mM Pi (Pi-cultures); (vi) 3.0 mM Pi and 
100 ng/ml LPS (Pi-LPS-cultures); (vii) 3.0 mM Pi plus 20% (v/v) bovine macrophage 
conditioned medium (Pi-bCM-cultures); (viii) 3.0 mM Pi, plus 100 ng/ml LPS, plus 20% 
(v/v) murine RAW264.7 macrophage conditioned medium (Pi-LPS-mCM-cultures); (ix) 3.0 
mM Pi, plus 100 ng/ml LPS, (Pi-LPS-bCM-cultures). In each cell culture supplemented with 
3.0 mM Pi, the final concentration of Pi was 3 mM. The treatments were performed for 3, 6, 
and 9 days, renewing the culture medium every 3 days. 
Concerning dystrophic-like conditions, pre-confluent AVICs were cultured using 4 sets of 
culture media each consisting in (i) DMEM plus 10% FBS, plus 1% L-glutamine, plus 1% 
penicillin/streptomycin (control cultures) or added with different volumes of 0.5 M sodium 
dihydrogen phosphate solution, thereby obtaining final Pi concentrations of (ii) 0.8 mM Pi 
(0.8-Pi-cultures), (iii) 1.3 mM Pi (1.3-Pi-cultures), and (iv) 2.0 mM Pi (2.0-Pi-cultures). 
Moreover, 4 sets were prepared of 0.8-, 1.3-, and 2.0-Pi-cultures with further addition of 100 
ng/mL LPS and 20% (v/v) bovine macrophage conditioned medium (0.8-Pi-LPS-CM-
cultures, 1.3-Pi-LPS-CM-cultures, and 2.0-Pi-LPS-CM-cultures, respectively). The treatments 
were performed for 3, 9, 15, 21, 25, and 28 days, renewing the culture medium every three 
days.  
To ascertain whether apoptosis is involved in AVIC pro-calcific degenerative processes, a 
parallel set of 2.0-Pi-LPS-CM-cultures was treated with a pre-validated concentration of 20 
µM pancaspase inhibitor Boc-D-FMK (Sigma-Aldrich) for 28 days renewing culture medium 
every three days. 
In order to assess the effects of low density lipoproteins (LDLs) in pro-calcific 
degenerative process, AVICs were cultured with 50	  µM of native LDLs (nLDL-clutures) or 
aggregated LDLs (agLDL-cultures) alone or combined with pro-inflammatory stimuli Pi (2.0 
or 3.0), LPS and bCM (2.0-Pi-LPS-bCM-nLDL-, 2.0-Pi-LPS-bCM-agLDL-, 3.0-Pi-LPS-
bCM-nLDL- and 3.0-Pi-LPS-bCM-nLDL-cultures, respectively). The treatments were 
performed for 3, 6, and 9 days in metastatic-like conditions, and for 3, 9, 15, and 21 days in 
dystrophic-like conditions culture medium was renewed every three days.  
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3.7 LIGHT MICROSCOPY 
3.7.1 ALIZARIN RED S CALCIUM STAINING 
After culture medium removal, AVIC monolayers were rinsed with phosphate buffer and 
fixed with neutral-buffered 5% formalin for 10 min. After further rinsing, cultured cells were 
treated with an aqueous solution of 2% alizarin red S (Carlo Erba Reagents), pH 4.2, for 5 
min, rinsed again to remove exceeding staining solution, and covered with distilled water. As 
negative control, parallel AVIC monolayers were treated with a decalcifying solution 
containing 0.05 M sodium acetate buffer and 0.05 M magnesium chloride, pH 4.8, for 1 h at 
room temperature prior to alizarin red staining. Observations and photographic records were 
made using an Olympus IX70 inverted microscope. 
 
3.7.2 VON KOSSA SILVER STAINING 
8-µm-thick cryosections were serially cut and mounted on poly-L-lysine pre-coated glass 
slides, air-dried, fixed with phosphate-buffered 5% formaldehyde, and subjected to von Kossa 
silver reaction for the evidentiation of calcium binding sites. Namely, the cryosections were 
treated with 1% silver nitrate aqueous solution, with exposure to direct sunlight, for 15 min, 
rinsed with distilled water, dipped into a 5% sodium thiosulfate reducing solution for 5 min, 
and rinsed again. von-Kossa-reacted cryosections were weakly counterstained with 
hematoxylin and eosin, dehydrated in graded ethanols, cleared with xylene, and mounted with 
Eukitt® mounting medium. Observations and photographic recording were made using Zeiss 
AxioImager and Leica DM 2500 photomicroscopes, the latter being a part of an InVia Raman 
microscope (Renishaw). 
 
3.8 TRANSMISSION ELECTRON MICROSCOPY 
3.8.1 PRE-EMBEDDING CUPROLINIC BLUE REACTION 
After culture medium removal, AVIC monolayers were washed twice with 0.1 M 
phosphate buffer and subjected to pre-embedding reaction with 0.05% phthalocyanin 
Cuprolinic Blue (CuB; Electron Microscopy Sciences) dissolved in 25 mM sodium acetate 
buffer, containing 0.05 M magnesium chloride and 2.5% glutaraldehyde, pH 4.8, overnight, at 
room temperature. After further washing, AVICs were post-fixed with phosphate-buffered 2% 
osmium tetraoxide (OsO4) (Agar Scientific) for 1 h at +4°C, washed again, dehydrated in 
graded ethanols, and embedded in Epon 812 resin. 
Similarly, samples obtained from explanted human valve leaflets were minced into 1-2 
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mm3 pieces and subjected to pre-embedding CuB reaction for polyanion evidentiation. 
Namely, samples were treated with 0.05% CuB dissolved in acid (pH 4.8) 25 mM sodium 
acetate buffer, added with 0.05 M magnesium chloride and 2.5% glutaraldehyde, for 3 days at 
room temperature under continuous agitation using an Agar rotator. After washing with acid 
buffer as above, samples were post-fixed with phosphate-buffered 2% OsO4, dehydrated in 
graded ethanols, and embedded in Epon/Araldite.  
Ultrathin sections were collected on formvar-coated 2x1-mm-slot copper grids and 
contrasted with uranyl acetate and lead citrate. Ultrastructural examination and photographic 
recordings were made using a Philips CM12 STEM transmission electron microscope. 
 
3.8.2 POST-EMBEDDING VON KOSSA SILVER REACTION 
Semithin sections of CuB-reacted AVIC monolayers were mounted on glass slides, 
covered with a drop of 1% silver nitrate aqueous solution, and placed on an +80°C warm plate 
for 15 min under direct sunlight. After washing with distilled water and drying, semithin 
sections were covered with a drop of 5% sodium thiosulfate reducing solution and warmed at 
80°C for 5 min. After further washing and drying, reacted semithin sections were re-
embedded by gluing onto the slides top-less conic Beem capsules (Agar Scientific), so 
encircling each semithin section, which were filled with Epon-Araldite fluid. After resin 
polymerization, re-embedded sections were detached from slides and subjected to standard 
electron microscopy processing. 
 
3.8.3 ULTRASTRUCTURAL LOCALIZATION OF ACID PHOSPHATASE ACTIVITY 
Acid phosphatase activity was revealed according to Gomori’s method. Briefly, AVIC 
monolayers were fixed with 3% paraformaldehyde for 30 min, washed with sodium acetate 
buffer, pH 5.0, and incubated with 0.05 M sodium acetate buffer, containing 0.01 M beta-
glycerophosphate and 0.004 M lead nitrate, pH 5.0, for 45 min at 37°C. As negative control, 
incubating solutions lacking in beta-glycerophosphate were used. After washing with cooled 
sodium acetate buffer to block enzymatic activity, AVIC monolayers were (i) fixed with 2% 
glutaraldehyde for 15 min, (ii) post-fixed with 2% osmium tetraoxide for 1 h at 4°C, (iii) 
dehydrated in graded ethanols, and (iv) embedded in Epon 812 resin. Thin sections were 
collected, contrasted, observed, and recorded as above. 
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3.9 RAMAN MICROSPECTROSCOPY 
Concerning AVIC cultures, cells were seeded on CaF2 slides and treated with DMEM plus 
10% FBS, 1% L-glutamine, and 1% penicillin/streptomycin (i) alone (control cultures) or (ii) 
combined with 3.0 mM Pi, LPS, and bCM (Pi-LPS-bCM-cultures). The treatments were 
performed for 9 days, renewing the culture medium every three days. At day 9, slides were 
dried and stored at room temperature until microspectroscopic examination. 
Concerning histological samples, longitudinal, 15-µm-thick cryosections were mounted on 
CaF2 slides, air-dried, and stored at -20°C until microspectroscopic examination.  
Raman maps were collected in back scattering geometry, with the above InVia Raman 
microscope (Renishaw) equipped with a 785 nm diode laser (Renishaw) delivering 90 mW of 
laser power at the sample. The CaF2 slide supporting the tissue samples was mounted on a 
ProScan II motorized stage under the microscope. A Leica 50× microscope objective (N.A. 
0.85) focused the laser on the sample. A 1200 l/mm grating yielded a spectral resolution of 4 
cm-1. A thermoelectrically cooled charge coupled device (CCD) camera was used for 
detection. The spectrograph was calibrated using the lines of a Ne lamp. Mapping was 
achieved collecting spectra with steps of 12 µm, with 10 s exposure time for each spectrum, 
for a total of 5708 spectra, each consisting of 1203 data points. Spectra were obtained in the 
600-1800 cm-1 region using the synchro mode of the instrument software WiRETM 3.2 
(Renishaw), in which the grating is continuously moved to obtain Raman spectra of extended 
spectral regions. Data preprocessing (i.e. baseline subtraction, vector normalization) and 
analysis were made using the hyperSpec package (Beleites C. and Sergo V., 2013) for R (R 
Core Team, 2013). 
 
3.10 CALCIUM QUANTIFICATION 
After culture medium recovering, cells were scraped from each culture plate, centrifuged, 
and treated with an aqueous lysis buffer containing 50 mM TRIS-HCl, 150 mM NaCl, 5 mM 
EDTA, and 1% Triton X-100, pH 7.4, for 1 h at +4°C. After centrifugation at 2000 g for 5 
min, part of supernatant (500 ml) was recovered for ALP activity/protein assay and remaining 
lysed samples were rejoined to their original culture media and transferred into distinct Teflon 
vessels. Samples were added with 1 ml of 65% supra-pure grade nitric acid (Merck) and 500 
ml of 30% supra-pure hydrogen peroxide (Merck), irradiated using the High Performance 
Microwave Digestion Unit mls 1200 mega (Milestone; 2 min at 250 W, 2 min at 0 W, 5 min 
at 300 W, 5 min at 450 W, and 6 min at 650 W), and diluted with ultra-pure water until 
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obtaining 100 ml of total solution. Calcium quantification was assessed using the O-
cresolphtalein complexone method (Chema Diagnostica) and absorbance was read at 575 nm 
with a Cary 50 Bio spectrophotometer (Varian). Each estimation came from 10 readings of 
five distinct experiments. 
 
3.11 ALKALINE PHOSPHATASE ACTIVITY ASSAY 
Supernatants (500 µL) obtained from micro-centrifugation of lysed samples were used to 
determine ALP activity and protein content. ALP activity was assessed using a kinetic method 
based on measurement of 4-nitrophenol production (Chema Diagnostica) reading the 
absorbance at 405 nm at +37°C within 5 min of enzymatic activity using the Cary 50 Bio 
spectrophotometer. Values corresponding to the trend line gradients coming from reading of 
five distinct experiments were normalized on the basis of protein content 
spectrophotometrically estimated by Bradford method using a commercial kit (Pierce). 
 
3.12 IMMUNOCYTOCHEMISTRY 
Control-cultures, 1.3-Pi-LPS-CM-cultures, and 2.0-Pi-LPS-CM-cultures were obtained by 
seeding AVICs on 24x24 mm cover slips placed at the bottom of 35 mm culture plates and 
culturing them for 3, 9, 15, and 21 days. After culture medium removal, AVIC monolayers 
were incubated with (i) 0.1% Triton X-100 solution for 10 min, (ii) 3% hydrogen peroxide 
solution for 5 min, (iii) 3% normal serum solution for 30 min, (iv) 1:600 anti-MAP1LC3-A 
polyclonal antibody (Merck Millipore) or 1:25 anti-annexin-V polyclonal antibody (Santa 
Cruz Biotechno-logy) for 2 hs at room temperature in a humidified chamber. Primary 
antibodies were replaced by normal serum, as negative control. After washing, AVIC 
monolayers were incubated with peroxidase-conjugated secondary antibodies (Jackson 
ImmunoResearch) for 30 min at room temperature. Peroxidase activity was revealed by 
incubation with diaminobenzidine tetrahydrochloride (DAB) and hydrogen peroxide (Vector 
Laboratories) for 3-6 min. After rinsing with distilled water to block enzymatic activity, 
AVIC monolayers were weakly counterstained with hematoxylin. Cover slips were then 
mounted on glass slides using an aqueous mounting medium, observed, and recorded using a 
Zeiss AxioImager photomicroscope. Percentages of immunopositive cells were estimated 
using the ImageJ software. 
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3.13 POLYACRYLAMIDE GEL ELECTROPHORESIS 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli 
U.K., 1970) was performed using 10x10x0,1 cm gels. The acrylamide concentration in the 
separating gel was chosen according to the molecular size of the proteins to be separated, 
varying from 8 to 13% acrylamide and maintaining a acrylamide: N,N’-
methylenebisacrylamide ratio of 37.5:1 (w/w), which were solubilized in 0.25  
M glycine, 0.025 M Tris/HCl, pH 8.8 and 0.1% (w/v) SDS. The stacking gel was prepared 
using 4% (v/v) acrylamide in stacking buffer (0.125 M Tris/HCl, pH 6.8, 0.1% (w/v) SDS). 
0.1% ammonium persulfate and 0.0015% (v/v) TEMED were added to start gel 
polymerization.  
Electrophoresis was performed with a limiting voltage of 250 V and a current of 15 mA 
until the dye front reached at the bottom of the gel. The electrophoresis system was cooled 
using an internal fan to circulate water. Protein molecular weights were estimated by running 
standard proteins of known molecular weight in separated lanes (Bio-Rad). 
 
ACRYLAMIDE 17% RUNNING BUFFER (one gel)  
40%Acrylamide/bis-Acrylamide solution (Sigma) 2,55 ml 
dH2O 3,45 ml 
10% SDS   60 µl 
10% Ammonium persulfate 60 µl 
Temed (N,N,N’,N’–Tetramethylethylenediamine)    9 µl 
 
ACRYLAMIDE 4% STACKING BUFFER (one gel)  
40%Acrylamide/bis-Acrylamide solution (Sigma) 0,2 ml 
dH2O 1,8 ml 
10% SDS   20 µl 
10% Ammonium persulfate 20 µl 
Temed (N,N,N’,N’–Tetramethylethylenediamine)    5 µl 
 
ELECTROPHORESIS BUFFER  
Glycine 250 mM 
Tris/HCl pH 8.8 25 mM 
SDS  0.1% p/v 
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3.14 WESTERN BLOT ANALYSIS 
After cell lysis and protein quantification, supernatants from 3-, 9-, 15-, and 21-day-long 
control-cultures, 1.3-Pi-LPS-CM-cultures, and 2.0-Pi-LPS-CM-cultures were separated by 
SDS-PAGE and transferred to 0.2 µm pore size nitrocellulose membranes (Schleicher & 
Schuell, Bio Science) using a semi-dry blotting apparatus (TE 22 transfer unit from 
Amersham Biosciences). The transfer was performed at 2.5 mA/cm2 for 1 h in the transfer 
buffer. After staining with Ponceau S solution (ATX Ponceau S red staining solution Fluka), 
to verify transfer efficiency, the nitrocellulose sheets were saturated with 3% (w/v) non-fat 
dry milk in PBS buffer plus 0.1% Tween 20 for 1 h at room temperature and then incubated 
with 1:500 anti-caspase-3 (cleaved form) polyclonal antibody (Cell Signaling Technology) 
overnight at 4°C. 
Blots were then rinsed three times with PBS buffer plus 0.1% Tween 20 and incubated for 
1 h 30’ with peroxidase-conjugated anti-rabbit-IgG (1:15,000) secondary antibody (Sigma-
Aldrich) at room temperature. The membranes were washed again three times in PBS buffer 
plus 0.1% Tween 20 and developed with chemiluminescence assay SuperSignal® West Dura 
(Thermo Scientific) with maximum exposure time of 4 hs. For accurate estimation of protein 
molecular weight, Precision Plus Protein Standard (Bio-Rad) was used. AVICs treated with 
apoptosis inducer etoposide (50 µM) for 18 hs were used as positive control. 
High-resolution images of the films were acquired using the scanner SF Launcher and 
processed using the program ImageQuant TL. 
 
 
TRANSFER BLOT BUFFER (pH 8.1 - 8.3)  
Tris/HCl  25 mM  
Glycin 192 mM 
Methanol 20% v/v 
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3.15 THIN LAYER CHROMATOGRAPHY 
Lipid extraction was done according to the method of Bligh and Dyer with less 
modifications (Bligh E.G. and Dyer W.J., 1959). 
According to estimated protein concentration, one aliquot of the cell suspension was 
extracted with methanol/dichloromethane (2:1 v/v). After solvent removal under an N2 
stream, the lipid extract was re-dissolved in dichloromethane. Samples were partitioned by 
thin layer chromatography (TLC), which was performed on silica G-24 plates. Three different 
concentrations of standards (a mixture of cholesterol, triglycerides, and cholesterol palmitate) 
were applied to each plate. The chromatographic developing solution was heptane/diethyl 
ether/acetic acid (74:21:4 v/v/v). The plate was completely dried and spots were stained with 
ethanol solution of phosphomolybdic acid (5% p/v) and sulphuric acid (5% v/v). The spots 
corresponding to free cholesterol (FC), triglycerides (TG), and cholesteryl esters (CE) were 
quantified by densitometry ImageQuant TL (BioRad) against the standard curve of 
cholesterol, triglycerides, and cholesterol palmitate, respectively, by using a computing 
densitometer (Spectra MAX 250, Molecular Devices). 
 
3.16 STATISTICAL ANALYSIS 
Concerning spectrophotometrical evaluations of calcium levels and ALP activity in 
metastatic-like conditions, statistical differences among control and the different AVIC 
treatments were assessed using the ANOVA test, with Bonferroni correction for multiple 
comparisons. Values with p < 0.0001 were considered to be statistically significant. Values 
were reported as mean ± standard deviation. 
Concerning other experiments, after using the Levene's test for analysis of variances, 
statistical significance was assessed using either the Student’s t-test for data showing 
homogeneity of variances or the Mann-Whitney test for data showing no homogeneity of 
variances. For both tests, values with p < 0.017 were considered to be statistically significant. 
Values were reported as mean ± standard deviation. 
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4. RESULTS 
 
 
4.1 METASTATIC CALCIFICATION 
The effects of pro-calcific agents in promoting cell-dependent mineralization were 
evaluated chemically and morphologically.  
The primary cultures of bovine aortic valve interstitial cells (AVICs) (Fig. 4.1) were 
stimulated with elevated  (2.6 mM) inorganic phosphate (Pi-cultures) alone or combined with 
the pro-inflammatory stimuli represented by lipopolysaccharide (LPS-cultures) and 
conditioned media from cultures of either xeno- or allogeneic macrophages stimulated with 
LPS (mCM-cultures and bCM-cultures, respectively). 
 
 
 
Figure 4.1. Bovine aortic valve interstitial cells (AVICs) spreading out from an aortic-valve-leaflet-
derived sample (AVL) on culture Petri dish. Tissues were treated with a cocktail of enzymes in order 
to digest collagen and elastin, so allowing spontaneous migration of AVICs from the valve 
interstitium and their adhesion to a Petri dish bottom. Scale bar: 50 µm. 
 
 
Morphologically, the mineralization rates induced by the applied treatments were readily 
recognizable under the inverted microscope on the basis of size and number of formed calcific 
nodules. The presence of calcific nodules was apparent only in Pi-cultures as well as the most 
marked calcification occurring in Pi-LPS-bCM-cultures (Fig. 4.2). 
AVLBA
AVL
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Figure 4.2. Inverted microscope micrographs of unstained AVIC monolayers. A-C: Absence of calcium 
precipitation in control cultures (A) and cultures treated with bCM alone (B) and LPS alone (C). D-H: 
Presence of calcium precipitation in monolayer cultures treated with elevated Pi alone (D), or combined with 
bCM (E), LPS (F), LPS and mCM (G), LPS and bCM (H). Scale bar: 50 µm.  
 
Spectrophotometric estimations of calcium amounts contained in digested samples from 
AVIC cultures after 9-day-long treatments are reported in Figure 4.3. Consistently with 
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morphological data, the mean values resulted for samples from control cultures, LPS-cultures, 
mCM-cultures, and bCM-cultures were similar to each other and were collectively lower than 
those in samples from the cultures supplemented with elevated Pi. Also, these higher values 
were similar to each other, except for the Pi-LPS-bCM-cultures, which contained even more 
mineral. 
 
     
Figure 4.3. Spectrophotometric estimation of calcium amounts for 9-day-long-cultured bovine AVICs 
with no treatment (Ctrl) or after different stimuli alone or combined, that is, lipopolysaccharide 
(LPS), murine conditioned medium (mCM), bovine conditioned medium (bCM), and elevated 
inorganic phosphate (Pi). The values are reported as mean + SD. The values concerning the treated 
cultures are significantly different (*) from those of control cultures, and those concerning Pi-LPS-
bCM-cultures are significantly different (**) from all others; p < 0.0001. 
 
Since alkaline phosphatase (ALP) is considered to play a key role in calcification, its 
enzymatic activity was investigated spectrophotometrically. 
The values of ALP activity in the 9-day-long AVIC cultures are reported in Figure 4.4. 
Compared to control-cultures, no change resulted for bCM-cultures, a weak increase for LPS-
cultures, and further weak increase for Pi-cultures. Marked increases resulted for the 
remaining cultures, being the highest values measured for Pi-LPS-cultures and linearly lower 
those for Pi-LPS-mCM-cultures and Pi-LPS-bCM-cultures, respectively. 
Comparing changes in calcium amounts with those in ALP activity, the values of calcium 
content were markedly increased for all five cultures containing elevated Pi, whereas higher 
ALP activity only resulted for the three cultures containing Pi and LPS. 
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Figure 4.4. Spectrophotometric estimation of ALP activity for 9-day-long-cultured bovine AVICs with no 
treatment or after the different stimulations as in Fig. 4.2. The values are reported as mean + SD. The values 
concerning the treated cultures are significantly different (*) from those of control cultures. 
 
Supplementary estimations of this parameter were supplied for all these cultures verifying 
the time course spanning 3-9 days (Fig. 4.5). In detail, enzymatic activity reached a maximum 
at 6-day-long incubation for Pi- and Pi-bCM-cultures compared with control-cultures, with a 
subsequent drop at 9 days. Conversely, enzymatic activity underwent a roughly linear 
increase up to day 9 for Pi-LPS-cultures, Pi-LPS-mCM-cultures, and Pi-LPS-bCM-cultures. 
 
 
Figure 4.5. Spectrophotometric estimation of ALP activity time course spanning 3-9 days for bovine AVIC cultures 
after all treatments involving the presence of elevated Pi. The values are reported as mean + SD. 
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Severity of cell alterations was assessed at the ultrastructural level on samples subjected to 
pre-embedding histochemical reactions with acidic mixtures of glutaraldehyde and copper 
phthalocyanin Cuprolinic Blue (CuB). Since this mixture allows sample decalcification with 
simultaneous retention of acidic-lipid-containing material resulting from the degradation of 
cytoplasmic organules and membranes, this method permits to detect features not 
recognizable by using standard technique and previously showed AVICs to undergo a 
peculiar degeneration for in vivo experimental models of accelerated calcification (Ortolani F. 
et al., 2002a; Ortolani F. et al., 2002b; Ortolani F. et al., 2003; Ortolani F. et al., 2007) as 
well as in vitro models simulating dystrophic calcification (Ortolani F. et al., 2010).  In 
addition, semithin sections of CuB-reacted samples were subjected to post-embedding von 
Kossa silver reactions based on metallic silver precipitation, widely used on histological 
sections to detect calcific sites. 
On thin sections, control AVICs showed well-preserved intracytoplasmic organules and 
lamellipodia with associated anchoring stress fibres (Fig. 4.6 A, B) and occasional autophagic 
vacuoles. 
As in controls, no apparent damage was appreciable for AVICs from bCM-cultures, and LPS-
cultures (not shown). In all cultures containing elevated Pi, a distinct cell degenerative 
process was observed which included (i) degeneration of cytoplasmic organelles, (ii) release 
of CuB-reactive material, and (iii) margination of this material and its outward budding. In 
more detail, initial AVIC alteration consisted in the abnormal dilation of rough endoplasmic 
reticulum, swelling of mitochondria with progressive dissolution of their cristae, cytoplasm 
vesiculation, mounting loss of all membrane-bound organules and nuclear envelope, with the 
appearance of a lot of phthalocyanin-reactive lipid droplets, autophagocytic vacuoles/ 
lysosomes, and myelin figures (Figs. 4.6 D, G, H and 4.7 A, C, D). 
Cytoplasm vacuolization also depended on depletion of swollen mitochondria and was 
complicated by their joining/fusion into greater vacuoles. During these processes, previously 
accumulated lipid-like amorphous material seemed to be poured into the major vacuoles, 
transforming them into lipid inclusions subsequent to fragmentation and dissolution of lining 
membranes (Figs. 4.6 H and 4.7 C). 
The resulting lipid inclusions underwent a progressive increase in reactivity to pre-
embedding reaction with CuB (Figs. 4.6 G and 4.7 A) and were selective sites for metallic 
silver particle deposition, after additional post-embedding von Kossa silver staining (Fig. 4.7 
B). An incipient increase in cytoplasm electrondensity seemed to result from the melting of 
these reactive lipid droplets with associated overgrowing deposition of amorphous 
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phthalocyanin-positive material (PPM), which entrapped organule-derived remnants and 
clusters of degrading ribosomes (Figs. 4.6 H and 4.7 D). 
More advanced degenerative features were (i) shortening/disappearance of lamellipodia, 
with cells acquiring smoothed profiles and irregularly roundish shapes, (ii) complete 
colliquation of organelles, and (iii) their replacement by increasing PPM. Centrifugal PPM 
spreading in waves followed, resulting in the appearance of multilaminated, CuB-reactive 
PPLs outlining the body of cell remnants and being 100-200 nm thick (Figs. 4.6 E and 4.7 E). 
Initial pseudo-orthogonal precipitation of needle-like HA crystals appeared mostly to occur at 
level of PPLs, revealing their marked involvement as HA nucleators (Fig. 4.7 F). The same 
role was exhibited by initial PPL- derived bodies, detaching from cell surface and, to a lesser 
extent, intracellular transitional forms of PPM into PPLs. Co-localization between HA crystal 
nucleation and metallic silver precipitation was also evident after von Kossa reactions (Fig. 
4.7 G). 
These degenerative steps appeared to end with the dead PPL-lined cells undergoing 
fragmentation into heterogeneously sized bubbling bodies (Fig. 4.8 A, B), with overlapping 
sporulation-like PPL budding and pinching off. The resulting rounded concentrically 
laminated calcospherulae were mostly characterized by a punctate dense core and diameters 
ranging between 130 nm and 1 µm (Fig. 4.8 A-E). Also these PPL-derivatives were strongly 
reactive to silver von Kossa reactions (Fig. 4.8 F). 
It is worth noting that stimulation with elevated Pi alone was sufficient to give rise to all 
degenerative patterns including the genesis of calcospherulae (Fig. 4.6 D). Of interest, 
calcospherulae phagocytated by still viable AVICs were encountered (Fig. 4.6 C). 
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Figure 4.6. A and B: Thin sections showing normal features in AVICs from control-cultures. C-F: Altered 
features in AVICs from cultures added with 2.6 mM Pi: autophagocytic vacuole (double arrowhead in D); 
myelin figure (double white arrow in D); CuB-reactive layers (frame-PPL in E); calcospherulae (black 
arrows in D and F); phagocyted calcospherula (arrowhead in C); hydroxyapatite crystals (HA in D). G: 
CuB-reactive lipid droplets (LD) in an AVIC cultured with PiþLPS. H: Vesiculation and CuB-reactive 
material (PPM) in an AVIC cultured with Pi+LPS+mCM. Scale bars: 2,5 µm (A); 1 µm (B-D); 0.5 µm 
(E); 1 µm (F); 0.5 µm (G); 1 µm (H).  
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Figure 4.6. A-G: Thin sections showing altered features in AVICs from cultures added with 2.6 mM-Pi+LPS+bCM: 
CuB-reactive lipid droplets (LD in A); selective precipitation of metallic silver (Ag with arrows in B and G); 
vesiculation (in C and D) with inter-vesicle lipid material pouring (asterisks in C); CuB-reactive material (PPM in D); 
CuB-reactive multi-laminated layer (frame-PPL in E); hydroxyapatite crystals (HA in F and G). Scale bars: 0,5 µm. 
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Fig. 4.8. A-F: Thin sections showing cell-derived products subsequent to fragmentation of AVICs from cultures 
added with 2.6 mM Pi+LPS+bCM: concentrically laminated calcospherulae (CS with arrows in A-C); bubbling 
bodies (single arrows in B); and minor fragments showing CuB-reactive layers (frame-PPL in A, D, and E); selective 
precipitation of metallic silver (Ag with arrows in F). Scale bars: 2,5 µm (A, B); 0,5 µm (C-F). 
 
Raman microspectroscopy was used to provide further chemical informations about pro-
calcific degeneration of cultured AVICs after stimulations with the most effective 
mineralizing stumulation (Pi-LPS-bCM-cultures). Cultured AVICs were seeded on fluorite 
glasses because this material expresses a single Raman vibrational band not interferring with 
the signal generated by the sample. 
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Raman imaging showed HA to be mainly distributed at cell edges, with additional 
localization in the cytoplasm under form of HA foci (Fig. 4.9 A). HA major distribution was 
consistent with that of needle-shaped apatite crystals along AVIC surfaces displayed by 
electron microscopy (Fig. 4.6 F, G), as well as peripheral PPL location (4.9 B).  
 
 
 
Figure 4.9. A: Raman pattern of hydroxyapatite (HA) distribution in the AVIC as in 4.9 B. B: 
Ultrastructural picture showing PPL-lined degenerating AVIC from xenogenic subcutis implant (from 
human stenotic valve) after pre-embedding Cuprolinic blue reaction. Magnification: 5,000 x.  
 
On the basis of this topographical similarity, the same AVIC shown in Figure 4.9 A was 
analysed to achieve chemical detection of organic components (Fig. 4.10 B) and compared 
with control (Fig. 4.10 A). In detail, the Raman spectrum showed the characteristic peaks for 
HA at 959 cm-1 and for nucleic acids at 1570 cm-1. The presence of proteins was inferred by 
both the phenylalanine peak at 1060 cm-1, and the amide-I protein peak at 1500-1700 cm-1. 
The peak at 1128 cm-1 indicated the presence of saturated fatty acid chains, whereas the peak 
at 1650 superimposed to that of amide I, revealed the presence of unsaturated lipids. Finally, 
the deformation peak of acetylic and methylenic groups at almost 1450 cm-1 indicated the 
presence of both types of lipids.  
Maxima of HA distribution were displayed by cell-derived extracellular particles. 
Additionally, clusters of HA, lipids and proteins were detected at peripheral cell cytoplasm 
Electron MicroscopyRaman: Hydroxyapatite
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(Fig. 4.10 B). Most HA appeared to be arranged under form of a stratified outer cluster (green 
coloured pixels) and an adjacent inner cluster (light blue coloured pixels), in which lipids 
were present too. Characteristically, the multiple stratified cluster pattern depicted the cells as 
target-like structures, with a core cluster corresponding to nuclear proteins and nucleic acids, 
and a series of outer clusters corresponding in the order to cytoplasm organules and layers 
containing various quantities of HA, lipids and proteins. On examining relative peaks on 
Raman spectra, it is noteworthy that the amount of proteins decreases gradually, moving 
toward AVIC periphery, with parallel increasing of HA amounts. Concerning lipid 
components, peak analysis revealed a very weak lowering of lipids within the more and more 
external layers, indicating a persistent presence of lipids together with HA. 
 
 
Figure 4.10. A: Map of Raman spectra (centre) corresponding to multivariate hard clustering analysis on an area 
(square) of a cultured not treated AVIC (left) and relative spectra (right). B: Cluster map (left) and relative 
spectra (right) as in A on a cultured AVIC after 9-day-stimulation with Pi + LPS + bCM.  
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4.2 DYSTROPHIC CALCIFICATION 
Once characterized the mineralizing process regarding metastatic calcification, the 
investigation was extended to in vitro models simulating dystrophic calcification. 
Since Pi was previously found to represent a critical pro-calcific agent, AVICs derived 
from bovine valve leaflets were stimulated with different concentrations of Pi spanning the 
entire normophosphatemic range (0.8 mM, 1.3 mM and 2.0 mM) alone or combined with LPS 
and bCM.  
Presence of calcific nodules was histochemically assessed using alizarin red (Fig. 4.11). 
 
 
 
     
Figure 4.11. Inverted microscope micrographs of alizarin red stained AVIC monolayers at 21 days of 
stimulation. A-D: Absence of calcium precipitation in 0.8-Pi-cultures (A), 0.8-Pi-LPS-bCM-cultures (B), 
1.3-Pi-cultures (C), and 1.3-Pi-LPS-bCM-cultures (D). E and F: Presence of calcium precipitation in 2.0-
Pi-cultures (E), and 2.0-Pi-LPS-bCM-cultures (F). Scale bars: 250 µm. 
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Under inverted microscope, no alizarin red stained calcific nodules appeared for controls, 
0.8- Pi-cultures, and 1.3-Pi-cultures as well as 0.8-Pi-LPS-bCM-cultures and 1.3-Pi-LPS-
bCM-cultures, whereas nodule formation and increase occurred for 2.0-Pi-cultures, being the 
calcific process exacerbated for 2.0-Pi-LPS-bCM-cultures. 
As for metastatic calcification, spectrophotometrical analyses were performed to gain a 
quantitative evaluation of calcium amounts and ALP activity in the different AVIC cultures 
(Fig. 4.12). Both parameters resulted to be correlated with Pi concentrations and incubation 
times, being mineralization enhanced by the additional stimuli used.  
 
 
 
Figure 4.12. Spectrophotometrical estimations of calcium amounts (left column) and ALP activity (right column) for 
AVICs cultured with Pi at 0.8 mM (A, B), 1,3 mM (C, D) and 2.0 mM (E, F), alone or combined with pro-
inflammatory stimuli (LPS+bCM). The values are reported as mean + SD. The values concerning the Pi-LPS-bCM-
cultures significantly different from those of control cultures are indicated with black asterisk; the values concerning 
the Pi-cultures significantly different from those of control cultures are indicated with red asterisk; p < 0.01. 
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As in control cultures (Pi = 0.7mM), in 0.8-Pi-cultures and 0.8-Pi-LPS-bCM-cultures there 
was neither significant time-dependent changes nor stimulation-dependent ones (Fig. 4.12 A, 
B).  
Compared to control, 1.3-Pi-cultures and 1.3-Pi-LPS-bCM-cultures showed significantly 
higher Ca2+ amounts, which also moderately increased in the time course for 1.3-Pi-LPS-
bCM-cultures (Fig. 4.12 C). ALP activity resulted to be higher for only 1.3-Pi-LPS-bCM-
cultures whereas 1.3-Pi-cultures did not differed from control ones (Fig. 4.12 D). In addition, 
this increase in enzymatic activity stopped at 25 day with subsequent decrease as previously 
assessed for metastatic calcification. 
Compared to control, 2.0-Pi-cultures and 2.0-Pi-LPS-bCM-cultures showed similar trends 
as those for 1.3-Pi-cultures and 1.3-Pi-LPS-bCM-cultures until day 21, although exhibiting 
higher values (Fig. 4.12 E, F). Namely, at longer incubation times distinct exceptions 
consisted in (i) drastic increasing in both Ca2+ and ALP activity for 2.0-Pi-LPS-bCM-cultures, 
and (ii) striking increasing in ALP activity for 2.0-Pi-cultures starting from day 25. 
Ultrastructurally, in 2.0-Pi-cultures and, at greater extent, 2.0-Pi-LPS-bCM-cultures, 
severity of cell alterations was found to increase with a time-dependent pattern, according to a 
lipid-release-associated cell degenerative process which was superimposable to that 
previously described for cultured AVICs (Ortolani F. et al., 2010). Briefly, initial AVIC 
degenerative features consisted in (i) a widespread swelling of mitochondria and other 
organelles and parallel dissolution of their membranes with appearance of lipid droplets 
undergoing progressive acidification, so acquiring reactivity for the pre-embedding CuB 
reaction (Fig. 4.13 A), as well as calcium binding capacity, as revealed by post-embedding 
von Kossa silver staining (Fig. 4.13 B), and (ii) progressive disappearance of these droplets 
and organelles concurrently with progressive intracytoplasmic release and accumulation of 
amorphous lipid material showing analogous positivity for this phthalocyanin (PPM) and 
silver. More advanced degenerative features consisted in centrifugal PPM spreading and 
segregating at cell surface in form of phthalocyanin positive layers (PPLs) (Fig. 4.13 C), 
maintaining strong positivity for metallic silver precipitation (Fig. 4.13 D) as well as marked 
capacity of nucleating HA crystals, being directly exposed to the extracellular Pi-enriched 
milieu (Fig. 4.13 E). Further feature shared with metastatic calcification was the appearance 
of final degeneration products consisting in a population of variously sized PPL-lined 
irregular particles and pinching off of roundish PPL-lined calcospherulae, with superimposed 
affinity to metallic silver deposition, and associated HA nucleation (Fig. 4.13 F-H). 
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Figure 4.13. 2.0-Pi-LPS-bCM-cultures at different days of stimulation. Cytoplasm enriched in lipid droplets at 
day 9 (A and B). PPM peripheral exudation forming phthalocyanin-positive layer (PPL) at days 21-28 (C, D). 
CDPs and CDP-derived paracrystalline calcospherulae at day 28 (E-H). Silver staining of calcium binding sites 
within lipid droplets (B), plasmamembranes (D), and calcospherulae (G, H). Scale bars: 0,5 µm (A-E); 0,25 µm 
(G, H).  
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Control AVICs exhibited well-preserved organelles with co-existent numbers of 
autophagic vacuoles (Figs. 4.14 A, B). Compared to controls, AVICs from 0.8-Pi-cultures and 
1.3-Pi-cultures showed mild time-dependent changes, whereas those from 0.8-Pi-LPS-bCM-
cultures and 1.3-Pi-LPS-bCM-cultures (Figs. 4.14 B, C) exhibited shared patterns of more 
marked changes. Namely, earlier mild modifications were apparently decreased distribution 
of autophagic vacuoles. Subsequent changes consisted in on going organule alterations and 
increasing hypertrophy of rough endoplasmic reticulum (RER), so lining discrete cytoplasm 
regions occupied by more or less degraded organules (Figs. 4.14 C, D). Further RER 
overgrowth resulted in multiplication of cytoplasm compartments concurrently with a 
reduction of their size, up to envelope single mitochondria or their remnants (Figs. 4.14 D, F; 
4.15 A, C).  
In addition, Gomori’s ultracytochemical reactions revealed acid phosphatase activity to be 
present within RER lumen, at RER membrane, and even at level of the degrading 
mitochondria enveloped by this abnormally grown organule (Figs. 4.15 B, D), in contrast with 
control-cultures in which very low enzyme activity was exhibited by RER (not shown). Since 
the samples derived from all AVIC cultures were subjected to pre-embedding reaction CuB, 
enhanced electrondensity was exhibited by nuclear chromatin, lysosomes, and autophagic 
vacuoles, as expected. However, it is noteworthy that additional positivity to this 
phthalocyanin was occasionally encountered for 1.3-Pi-LPS-bCM-cultures, which was 
exhibited by cell degradation products similar to those characterizing the early degenerative 
features exhibited by AVICs from both 2.0-Pi-cultures and 2.0-Pi-LPS-bCM-cultures, i.e. 
lipid droplets and intracytoplasmic electrondense material (PPM), as described above. 
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Figure 4.14. Thin sections showing features in AVICs from control-cultures (A and B), with 
autophagosomes (B; white asterisks); and from 1.3-Pi-LPS-bCM-cultures (C and D) with 
autophagosomes (C) and abnormal enlargement of rough endoplasmic reticulum (ER) enveloping 
degraded organule-containing compartments (D-F, red asterisks). Scale bars: 1 µm (A,B); 0,5 µm 
(C, D); 0,5 µm (E, F).  
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Figure 4.15. Electron micrographs of 1.3 mM-Pi-LPS-bCM cultured AVICs. Increasing 
cytoplasm compartmentalization by enlarging endoplasmic reticulum (ER). Positivity to 
acid phosphatase activity indicated by lead-containing black particles, at level of (i) ER 
lumen (B, D: arrows), (ii) ER-mitochondria contact sites (solid arrowheads) and (iii) 
enveloped degrading organules or organule residues (B, D: empty arrowheads). Scale 
bars: 0,5 µm (A); 0,25 µm (B); 0,5 µm (C); 0,25 µm (D). 
 
 
To explore whether the described AVIC responses to the addition of Pi and the other 
stimuli correlate with macroautophagocytosis, additional immunocytochemical detection of 
marker MAP1LC3A was applied to control-cultures, 1.3-Pi-LPS-bCM-cultures, and 2.0-Pi-
LPS-bCM-cultures and summarized in Figure 4.16 G. The achieved data were consistent with 
those obtained with electron microscopy (Figs. 4.14 and 4.15) since marked reactivity after 3-
day-long incubation and its drastic decrease within 9 days of treatment, being still negligible 
after longer times, resulted for control-cultures (Fig. 4.16 A, B) and 1.3-Pi-LPS-bCM-cultures 
(Fig. 4.16 C, D). In contrast, there was minor positivity, besides its time-related decrease, for 
2.0-Pi-LPS-bCM-cultures (Fig. 4.16 E, F). 
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Figure 4.16. A-F: Immunocytochemical localization of MAP1LC3A on cultured AVICs stimulated with pro-
calcific stimuli and different concentrations of inorganic phosphate (Pi). Scale bar: 100 µm. G: Histogram of 
MAP1LC3A-reactive AVICs at different incubation times in the above cultures. The values are reported as 
mean ± SD. Asterisk indicates p < 0.001. 
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To assess possible involvement of apoptosis, other control-cultures, 1.3-Pi-LPS-bCM-
cultures, and 2.0-Pi-LPS-bCM-cultures were lysed and subjected to immunoblot detection of 
downstream marker caspase-3 to check the presence of the 17 kDa cleaved form of the 
enzyme, which is known to be required for this cell death program execution. Absence of 
cleaved caspase-3 even after the longest incubation times was assessed (Fig. 4.17). 
 
 
Figure 4.17. Western blotting showing absence of cleaved form of Caspase 3 in cell lysates obtained from AVICs 
cultured with pro-inflammatory stimuli (LPS + bCM) combined with inorganic phosphate (Pi) at two different 
concentrations with a time course of 3 to 21 days. 
 
Additional immunocytochemical detection of late marker annexin-V revealed weak 
immunoreactivity irrespectively from culture conditions and incubation timing (Fig. 4.18). 
Percentages of immunopositive cells are summarized in Figure 4.18 D. 
 
 
Figure 4.18. Exemplificative pictures showing scarce immunopositivity of AVICs to 
Annexin V (brown stained) in control cultures (Ctrl; A); 1.3-Pi-LPS-bCM-cultures (B); 
and 2.0-Pi-LPS-bCM-cultures (C), with only these latter showing calcific nodules (CN) 
after hematoxylin counter-staining. Scale bar: 50 µm. D: Histogram of Annexin-V-
reactive incubated AVICsat different incubation times in the above cultures.  
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Moreover, treatment of 2.0-Pi-LPS-bCM-cultures with pancaspase inhibitor Boc-D-FMK 
did not prevent nodule formation and showed degenerative patterns like cultures not subjected 
to caspase inhibition (Figs. 4.19 and 4.20). 
 
   
Figure 4.19. Inverted microscope micrographs of unstained AVIC monolayers at 21 days showing 
absence of calcium precipitation in control cultures (A) and cultures treated with pancaspase inhibitor 
BOC-FMK (B) and mineral precipitation in 2.0-Pi-LPS-bCM-cultures (C) and 2.0-Pi-LPS-bCM-
cultures plus BOC-FMK (D). Scale bar: 50 µm. 
 
 	    
Figure 4.20. Ultrastructual pictures of AVIC cultures plus pancaspase inhibitor BOC-FMK (A), and 
2.0-Pi-LPS-bCM-cultures plus BOC-FMK, showing the appearance of phthalocyanin positive layer 
(PPL) and CDP formation (B). Scale bars: 1 µm (A) 0.5 µm (B). 
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4.3 STENOTIC VALVES 
Ultrastructural examination of surgically excised aortic valve leaflets from patients affected 
by CAVS revealed the presence of a heterogeneous repertoire of altered features, including 
the presence in AVIC cytoplasm of (i) electronlucent non-membrane bound lipid droplets 
which were reminiscent of esteryl-cholesterol droplets (Fig. 4.21 A), (ii) dark CuB-positive 
droplets likely formed by anionic lipids (Fig. 4.21 B), (iii) heterogeneous droplets dervived 
from merging of both (Fig. 4.21 A, B), (iv) cholesterol clefts within merged electron-lucent 
droplets (Fig. 4.21 C), and (v) extracellular electronlucent cholesterol clefts interspersed 
within heterogeneous drifts of dark lipid material and cell debris (Fig. 4.21 D). 
 
  
Figure 4.21. Pre-embedding reactions with Cuprolinic Blue on samples from para-nodular calcifiyng areasfigure in 
stenotic human valve leaflets. A: Electronlucent droplets and their fusion with dark droplets (arrowheads) in an 
AVIC. B: dark lipid droplets includind one with heterogeneous content (arrow) in a magrophage-like cell. C: Foam 
cells with intracytoplasmic cholesterol droplets and clefts. D: Cholesterol clefts in residual cell debris. Scale bars: 1 
µm (A, B); 2 µm (C); 1 µm (D). 
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As for in vitro model, Raman technique was used for chemical estimations on cryosections 
of samples from CAVS-affected aortic valve leaflets, which were compared with von-Kossa 
reacted histological sections. These latter showed heterogeneously sized dark calcific nodules 
randomly distributed along the outer side of cusp fibrosa layer (Fig. 4.22 A). Each nodule was 
surrounded by a lot of von-Kossa-positive AVICs and a lot of equally dark, irregular 
microprecipitates, which were even scattered throughout the entire fibrosa layer. This latter 
still exhibited its native feature including eosinophilia and a dense fibrous texture, which was 
subjected to increasing alterations moving toward the calcific nodules. At level of this 
interstitial tunica, native-type dense fibrous texture was subjected to increasing alterations in 
parallel with eosinophilia decrease, consistently with prominent collagen degradation, moving 
toward the calcific nodules.  
Figure 4.22 G shows the mean normalized Raman spectrum of the map of a paraserial 
cryosection on respect to the von Kossa stained one (Fig. 4.22 A). The spectrum shows 
characteristic peaks for HA at 959 cm-1, for phospholipids/ triglycerides at 719 and 1738 cm-1, 
for cholesterol at 700 and 741 cm-1, for carotenoids at 1158 and 1525 cm-1, for collagen at 
877, 922 and 939 cm-1 (van de Poll S.W. et al., 2003; De Gelder J. et al. 2007). The presence 
of unsaturated lipids can be inferred from the small but still distinguishable peak at 1660 cm-1, 
superimposed to the broad amide-I protein peak (1500-1700 cm-1), whereas the peaks at 1064 
and 1128 cm-1 indicate the presence of saturated fatty acid chains as well. The corresponding 
Raman maps indicate localization and concentration of HA, collagen, elastin, 
phospholipids/triglycerides, cholesterol, and carotenoids. HA distribution of (Fig. 4.22 B) 
coincided with the calcified areas as revealed by von Kossa staining in the histological 
cryosection (Fig. 4.22 A).  
Collagen distribution (Fig. 4.22 C) spanning the entire valve leaflet roughly correlated with 
the structure characterizing native valves. 
The distribution of phospholipids/triglycerides as observed in the Raman images correlated 
with that of HA as well as the von Kossa silver staining patterns (Fig. 4.22 D). Intensity of 
these lipid bands was very low in the area corresponding to the calcific nodule, likely because 
in this area they are masked by the overwhelming intensity of the precipitated HA. Additional 
co-localization patterns were shared by both cholesterol and carotenoids (Fig. 4.22 E and F). 
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Figure 4.22. A: von Kossa stained cryosection showing metallic Ag deposition on calcific sites (brown 
precipitates). B-F: Raman images of a para-serial cryosection with respect to that in A showing the 
distribution of hydroxyapatite (B), collagen (C), phospholipid/triglycerides (D), cholesterol (E), and 
carotenoids (F) with colours indicating the relative amounts as displayed in the chromatic scales on the 
left. Note that hydroxyapatite maximum coincides with a calcific nodule (cn) and co-localization of 
phospholipids/triglycerides, cholesterol and carotene at decreasing rates. G: Mean Raman spectrum of the 
Raman map, averaged over all the 5708 spectra. Intensity standard deviation, showing the spectral 
variability, is shown in light grey. For all spectra, excitation wavelength was at 785 nm, laser power was 
170 mW and acquisition time was 10 s. Magnification 5 x. 
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4.4 TREATMENTS WITH LIPOPROTEINS 
Since both electron microscopy and Raman microspectroscopy revealed the presence of 
cholesterol with assumable derivation from LDLs, the pro-calcific role of these lipoproteins 
was investigated by combining in vitro model used above with an atherosclerotic one in both 
metastatic and dystrophic conditions. 
AVICs were cultured with combinations of pro-calcific stimuli (Pi, LPS and bCM) and/or 
native LDLs (nLDLs) and aggregated LDLs (agLDLs), two forms which have been shown to 
exert distinct effects on cultured smooth muscle cells, e.g.	   intracellular cholesteryl ester 
accumulation (Llorente-Cortés V. et al., 1998).   
Figure 4.23 shows changes in intracellular esterified cholesterol (EC) and triglycerides 
(TG) contents assessed with thin layer chromatography (TLC) in a time course spanning 3-9 
days.  
 
 
Figure 4.23. Thin layer chromatography after 6-day-long administration to cultured AVICs of native (nLDL) or 
aggregated LDL (agLDL) alone or combined with pro-calcific stimuli (Pi, LPS and bCM) in metastatic (Pi 3.0 mM) 
conditions. Bands showing the content of esterified cholesterol (EC), triglycerides (TG) and free cholesterol (FC) are 
displayed. 
 
 
Densitometric analysis of EC and TG bands is reported in Figure 4.24 A and B, 
respectively. All values were normalized on respect with amounts of free cholesterol (FC), 
which is stable, because it is maintained in a critical concentration range in living cells (Small 
D.M., 1988).  
Compared to control cultures (Pi 0.7 mM), negligible changes in EC amounts resulted after 
stimulation with pro-calcific stimuli alone, in both dystrophic and metastatic conditions. 
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After treatment with LDL solely, nLDL-cultures showed significant increase of EC at 3 
days, compared to control cultures. Additionally these cultures showed mild, progressive 
decrease of EC content over time. Conversely, the same parameter did not changed 
significantly after addition of both pro-calcific stimuli and nLDL (2.0- and 3.0-Pi-LPS-bCM-
nLDL-cultures), even if a weak increase of EC was found in 3.0-Pi-LPS-bCM-nLDLcultures 
at day 6 and in 2.0-Pi-LPS-bCM-nLDL-cultures at day 9, possibly in some relation with Pi 
concentration. 
Concerning cultures added with agLDLs (agLDL-, 2.0-Pi-LPS-bCM-agLDL and 3.0-Pi-
LPS-bCM-agLDL-cultures), EC values were very higher than those in control cultures and 
other treated cultures.  
 
 
Figure 4.24. Thin layer chromatography quantification of esterified cholesterol (EC) content (A) 
and triglycerides (TG) content (B) normalized on free cholesterol (FC) content, after 
administration of n- or agLDL alone or combined with pro-calcific stimuli, at 3, 6 and 9 days. 
Asterisk indicates p < 0.01. 
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No changes in TG content were found in control-, nLDL-, 2.0-Pi-LPS-bCM- and 3.0-Pi-
LPS-bCM-cultures (Fig. 4.24 B).  
Significant increases were evident for all other cultures which showed maximum values at 
the intermediate incubation time, i.e. day 6. Of these, lower values resulted for metastatic-like 
conditions, i.e. 3.0-Pi-LPS-bCM-nLDL-cultures and 3.0-Pi-LPS-bCM-agLDL-cultures. 
First spectrophotometrical estimations of calcium amounts were performed fro metastatic-
like conditions  (Fig. 4.25).  
 
 
Figure 4.25. Spectrophotometric estimation of calcium amounts considering 3- to 9-day-time-course for bovine AVIC 
cultures after treatments with nLDL or agLDL, alone or combined with pro-calcific stimuli in metastatic conditions. 
The values are reported as mean + SD. Asterisks insicate the values concerning 3.0-Pi-LPS-bCM-nLDL- and 3.0-Pi-
LPS-bCM-nLDL-cultures at 9 days of stimulation significantly different from 3.0-Pi-LPS-bCM-cultures; p < 0.01. 
 
 
In detail, 3.0-Pi-LPS-bCM-cultures showed a time-dependent increase in calcium levels. 
Treatment with nLDLs showed mild pro-calcific effect, being calcium levels augmented at 
day 9, whereas there was a significant increase in calcium after treatment with agLDLs 
starting from day 3, remaining constant along the time course. Moreover, combination of 
nLDL with pro-calcific stimuli caused calcium levels to reach a maximum level at day 6, with 
subsequent weak decrease at day 9. Finally, 3.0-Pi-LPS-bCM-agLDL-cultures showed not 
only a rapid increase of calcium levels at day 3, which was comparable with those of 3.0-Pi-
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LPS-bCM-cultures at day 9, but also a further increase at day 9, reaching the highest level 
concerning all treatments. Thus a major pro-calcific role appeared to be played by agLDLs.  
In order to compare metastatic calcification with dystrophic one, the effects of nLDL and 
agLDL on calcium amounts were assessed in AVICs also in normophosphatemic-like 
conditions (Fig 4.26). In this experimental stage, culture time course was prolonged because 
calcium precipitation is less prominent than for metastatic-like conditions and longer 
adhesivity of AVICs to Petri dish is allowed. 
 
 
	    
Figure 4.26. Spectrophotometric estimation of calcium amounts considering a time course spanning 3-21 
days for bovine AVIC cultures after treatments with nLDL or agLDL, alone or combined with pro-calcific 
stimuli in metastatic conditions. The values are reported as mean + SD.	   Asterisks insicate the values 
concerning 2.0-Pi-LPS-bCM-nLDL- and 2.0-Pi-LPS-bCM-nLDL-cultures at 21 days of stimulation 
significantly different from 2.0-Pi-LPS-bCM-cultures; p < 0.01. 
 
 
As for metastatic-like calcification, a significant increase in calcium levels was found for 
2.0-Pi-LPS-bCM-cultures at the longest incubation times (15 and 21 days). Compared to 
control cultures, a progressive calcium increase was observed for nLDL-ones, indicating their 
possible pro-calcific effects. This was confirmed by ultrastructural patterns showing AVICs 
with several suffering features, such as the atypical enlargement of endoplasmic reticulum, 
that circumscribes discrete cytoplasm regions occupied by more or less degraded organules 
(Fig. 4.27 A and B). These patterns were superimposable to those described for mild 
normophosphatemic-like pro-calcific stimulation (Figs. 4.14 D-F and 4.15). 
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 Interestingly, a paradoxical effect of nLDLs was found in 2.0-Pi-LPS-bCM-nLDL-
cultures, because calcium levels were comparable to control cultures, at days 15 and 21. Also 
these data were confirmed by electron microscopy since 3.0-Pi-LPS-bCM-nLDL-cultured 
AVICs exhibited well-preserved organules, long stress fibres, unaltered cytoplasm and no 
evident features of cell degeneration even after long-time stimulation (Fig. 4.27 D).   
 
 
Figure 4.27.	  AVICs treated with nLDL solely (in A and B) showing abnormally dilated endoplasmic reticulum 
(ER), or combined with pro-calcific stimuli showing endocytosis vacuoles containing nLDLs (arrow), lipid 
droplets (LD) (in C) and stress fibers (in D). Scale bars: 1 µm (A); 0,5 µm (B, C); 2 µm (D). 
 
As for metastatic calcification, internalized agLDL (Fig. 4.28 A and B) correlated with 
increasing calcium levels starting from day 3, and its subsequent unchanging with time. 
Interestingly, agLDL-treated AVICs did not exhibit suffering features being similar to control 
ones (Fig. 4.28 A and B). By contrast, agLDL treatment combined with Pi and pro-
inflammatory stimulation exacerbated the pro-calcific effect resulting in higher levels of 
calcium with respect to 2.0-Pi-LPS-bCM-cultures, at 21 days.  
In fact, distinct patterns of typical pro-calcific degeneration were found in 3.0-Pi-LPS-
bCM-agLDL-cultures, as previously described, being included (i) CuB-reactive acid lipid 
droplets (Fig. 4.28 C) and the degenerative modifications culminating in the formation of (ii) 
PPL-lined irregular CDP and roundish calcospherulae (Fig. 4.28 D). 
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Figure 4.28. Cultured	   AVIC treated with agLDL solely (A and B) or combined with pro-calcific 
stimuli (C and D). A: Clusters of agLDLs in the medium. The agLDLs squared are magnified in the 
inset below-right. B: agLDLs internalized within an AVIC vacuole (squared) which is magnified in 
the inset below-left. C and D: Patterns of pro-calcific degeneration in 3.0-Pi-LPS-bCM-agLDL-
cultures. Cytoplasm Initial degeneration represented by formation of cytoplasmic lipid droplets (LD) 
and final degenerative products, represented by PPL-lined calcospherulae (CS). Scale bars: 2 µm (A, 
B) 0.5 µm (inset A, inset B); 1 µm (C, D). 
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5. DISCUSSION 
 
In the present investigation, calcific aortic valve stenosis (CAVS) was mimicked using in 
vitro models, assessing the effects of several pathologic agents, such as inorganic phosphate 
(Pi), pro-inflammatory stimuli (bacterial LPS and macrophage-derived inflammatory 
mediators) and subjecting the cultured aortic valve interstitial cells (AVICs) to pro-
atherosclerotic stimuli (LDLs). 
 The AVICs cultured at elevated Pi concentration, consistently with the hyper-
phosphatemic conditions in organisms, allowed to shed light on the crucial involvement of 
this inorganic element in a context reproducing metastatic calcification, since prominent 
calcific events occurred in all cultures containing elevated Pi (3.0 mM). As a matter, such a 
condition resulted to be capable of inducing ectopic calcification per se, consistently with the 
concept that elevated Ca x P product represents the most predictive parameter for cardiac 
valve calcification in hemodialysis patients (Ribeiro S. et al., 1998; Block G.A., 2000; Tarrass 
F. et al., 2006). Compared to Pi-cultures, additional increase in calcium amount resulted for 
Pi-LPS-bCM cultures exclusively. Absence of increase in calcium amounts after stimulation 
of 9-day-cultured AVICs with endotoxin LPS is not consistent with a previous report of 
marked mineralization occurring in Pi-LPS treated AVIC cultures (Rattazzi M. et al., 2008), 
although those results concerned longer incubation times. Conversely, in the present work the 
highest alkaline phosphatase (ALP) activity resulted for Pi-LPS treatment. Of note, direct pro-
calcific effects by LPS, including ALP activity enhancement, were shown to occur for 
cultured AVICs with the involvement of specific LPS Toll-like receptors (TLRs) (Babu A.N. 
et al., 2008; Meng X. et al., 2008; Yang X. et al., 2009). Thus, it seems likely that this 
bacterial endotoxin can exert some pro-calcific effect on AVICs, superimposing to that 
exerted by elevated Pi. Additional stimulations with conditioned media derived from cultures 
of monocytes/macrophages in their turn stimulated with LPS, were accomplished with the 
rationale of simulating inflammatory conditions due to bacterial infection in the organism. 
Treatment with conditioned medium from LPS-stimulated monocytes/macrophages on a 
subset of bovine aorta-wall-derived smooth muscle cells (Tintut Y. et al., 2002) named 
calcific vascular cells (CVCs)  (Watson K.E. et al., 1994), elicited TNF-α secretion and 
associated ALP activity increasing. Moreover, specific interaction of LPS with TLR-4 was 
reported to activate murine RAW264.7 macrophages, suggesting their contribution in 
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mineralizing processes (Hume D.A. et al., 2001; Wu T.T. et al., 2009). In this study, 
conditioned media from cultures of LPS-activated RAW264.7 macrophages did not cause 
increase in mineralization, whereas clear calcific overgrowth occurred by using conditioned 
media from cultures of allogeneic primary macrophages. Taking into account that 
macrophage activation by bacterial wall components correlates with secretion of species-
specific chemo/cytokines (Nagao S. et al., 1992) and that equal pathogen doses can trigger 
different inflammatory cell responses (Munford R.S., 2010; Warren H.S. et al., 2010), it is 
suggested that species-specificity of macrophage-derived cytokines is essential to enhance 
calcific responses by AVICs. 
Together, the above results are in line with the concept that products derived from Gram-
negative bacteria may contribute in triggering cardiac valve calcification via inflammatory 
reactions, as suggested by the detection of Chlamydia pneumoniae in both stenotic and 
sclerotic semilunar valves (Juvonen J. et al., 1997; Nyström-Rosander C. et al., 1997), as well 
as the experimental demonstration that animal aortic valves undergo mineralizing effects after 
inoculation with oral bacteria (Cohen D.J. et al., 2004). 
Concerning ALP activity in 9-day-long cultures, prominent increases were restricted to the 
three cultures subjected to stimulation with LPS and LPS plus conditioned media. Since 
prominent increase in calcium amount was a response shared by AVIC cultures with elevated 
Pi concentration, analogous sharing was expected to exist for ALP activity. Unpredictably, Pi- 
and Pi-bCM-cultures showed lower enzyme activity. However, on extending the estimation of 
ALP activity to 3-day and 6-day long cultures, similar increase was shared by all four culture 
types up to 6 incubation days, with a marked drop in Pi- and Pi-bCM-cultures between the 
sixth and the ninth day, in contrast with further increase occurring for the other three 
treatments. This was consistent with the reported finding of lower enzymatic activity for 
AVIC Pi-cultures versus Pi-LPS cultures (Rattazzi M. et al., 2008). Thus, it is reasonable that 
ALP activity may be involved in mineralization but without acting as exclusive driving factor. 
In addition, it cannot be excluded that in Pi-LPS-bCM-cultures increased cell degeneration 
entails lower ALP synthesis. 
Of interest, pro-inflammatory cytokines such as TNF-α were reported to induce over-
expression of type III sodium-dependent Pi cotransporter PiT-1 (Li X. and Giachelli C.M., 
2007), with a possible increase in Pi uptake by cultured mineralizing vascular smooth muscle 
cells (Lau W.L. et al., 2010). Putatively, a differential cytokine-induced overexpression of 
PiT-1 by AVICs and subsequent massive Pi uptake might enhance calcium phosphate 
formation, thereby eliciting greater HA precipitation at the edges of AVICs and AVIC-
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derived products in Pi-LPS-bCM cultures, independently from the rate of ALP activity. It is 
noteworthy that increases in ALP activity were never associated with signs suggesting some 
AVIC trans-differentiation into osteoblast-like cells, being the progression of calcific 
processes exclusively accompanied by advancing of the described pro-calcific degenerative 
patterns showed by the dying/died cultured AVICs. Although apoptosis was reported to occur 
for cultured ovine calcifying AVICs stimulated with transforming growth factor beta (TGF-β) 
(Jian B. et al., 2003) as well as a specific clone of bovine AVICs after stimulation with LPS 
(Rattazzi M. et al., 2008). Rather, the observation of frequent autophagic figures at the early 
treatment stages might suggest that autophagic cell death might be primed, as reported for 
CAVS (Somers P. et al., 2006), with the occurrence of unusually extensive lipolytic 
processes, possibly resulting in a prominent release of phospholipids and free fatty acids, 
consistently with the observed reactivity to cationic dye cuprolinic blue (CuB).  
Size and number of calcific nodules displayed by light inverted microscope for Pi-
containing cultures were morphological parameters fitting with the treatment-dependent 
increases in calcium amounts estimated by means of spectrophotometry. Consistently, 
ultrastructural analysis clearly indicated that all treated AVICs underwent dramatic 
breakdown including intracellular release/accumulation of CuB-reactive and silver-reactive 
material as well as its outcropping with formation of the pericellular dark layers named PPLs 
(phthalocyanin-positive-layers). A similar cell degradation process was already described for 
experimental in vivo calcification consisting in xenogenic subdermal implantation of 
glutaraldehyde-treated aortic valve cusps, with PPLs resulting to be largely formed by lipidic 
moieties including phospholipids and to contain calcium-binding sites (Ortolani F. et al., 
2002a; Ortolani F. et al., 2002b; Ortolani F. et al., 2003; Ortolani F. et al., 2007), as well as 
experimental in vitro models of ectopic calcification (Ortolani F. et al., 2010). Of interest, 
PPLs are comparable to the alcianophylic envelopes outlining so called "thick walled cell 
derived products" (CDPs), described for calcific aortic valves and other soft tissues affected 
by ectopic calcification (Kim K.M. and Huang S.N., 1971; Kim K.M., 1976; Boskey A.L. et 
al., 1988; Kim K.M., 1995). 
Since the production of the PPL precursor named PPM (phthalocyanin-positive-material) 
paralleled a progressive disappearance of all cytomembrane-bounded organelles, derived 
membranous residues and nuclear chromatin, it ensues that such a substance results from a 
complete colliquation of all these components. This was also confirmed by the observation of 
a lot of transitional patterns showing disrupting organelles or their ghosts to merge with PPM 
or to be embedded within such a material. 
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The role of these cell-derived products as major HA nucleators was supported by co-
localization of calcium binding sites, as revealed by the selective precipitation of metallic 
silver after von Kossa staining, as well as effective superimposition of HA crystals. A further 
significant outcome was the identification of multilayered PPLs and concentrically laminated 
calcospherulae, these latter being closely reminiscent of the typical "porous particles in 
concentric layering" described for calcific aortic valves and other tissues affected by ectopic 
calcification (Kim K.M., 1995) as well as failed calcific valve bioprostheses (Valente M. et 
al., 1985). 
Because of affinity to von Kossa silver staining and superimposition by HA crystals, the 
calcospherulae seem to act as mineralization enhancers in the most advanced calcific stages, 
providing a widespread dissemination of supernumerary nucleation sites. This role is 
analogous to that played by matrix vesicles and/or apoptotic bodies in both physiological 
calcification and pathological one (Anderson H.C., 1983; Kirsch T., 2006), although being 
quite different cell-derived structures. Indeed, calcospherulae appeared to result from passive 
budding of PPLs and lack in cytoplasm, showing a roughly shared para-crystalline structure 
because of the presumable rearrangement of the pre-existent array of the lipid moiety at the 
level of the PPL-forming layers. Conversely, matrix vesicles and apoptotic bodies are 
described to result from distinct regulated mechanisms, contain organized cytoplasm, and are 
outlined by membranes with specific molecular architectures, including either inner location 
of phospholipids (Wu L.N. et al., 1997) or outer location (Bratton D.L. et al., 1997), 
respectively. 
Consistently with electron microscopy, Raman analysis of stimulated calcifying cells 
revealed a peripheral distribution of type B carbonate HA, as revealed by the presence of the 
band at 959 cm-1, which was prevoiusly shown to correspond to such a salt (Penel G. et al., 
1998). Moreover, degenerating cells exhibited a target-like configuration of Raman clusters, 
with progressive HA increase toward external clusters. Paralleling a prominent decrease in 
protein amounts up to disappearcance, there was weaker decrease with persistence in the 
amount of lipids, predominantly the unsaturated ones, indicating their possible role as HA 
nucleators consistently with their ionic nature. This data fit with the histochemical reactivity 
of PPLs to phospholipid-specific malachite green staining at the ultrastructural level  
previously demonstrated using the subdermal model (Ortolani F. et al., 2003). 
Concerning the AVICs cultured with Pi concentrations spanning the normophosphatemic 
range in organism, the dystrophic-like mineralization processes provoked modifications that 
are consistent with priming of compensatory mechanisms of cell function preservation for the 
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two lowest Pi levels (0.8 mM and 1.3 mM). The cell responces correlated with the appearance 
of an unusually prominent RER-dependent organelle segregation and removal. In contrast, 
after treatment with the highest (2.0 mM) Pi concentration, the cultured cells underwent the 
described lipid-release-associated pro-calcific death and disruption, confirming the critical 
role played by Pi concentration in triggering the AVIC-dependent mineralization besides this 
process starting and advancing in similar manner as that previously described for in vitro 
AVIC experimental calcification (Ortolani F. et al., 2010; Bonetti A. et al., 2012), in vivo 
calcific subdermal models (Ortolani F. et al., 2002a; Ortolani F. et al., 2002b; Ortolani F. et 
al., 2003; Ortolani F. et al., 2007), and actual aortic valve stenosis (Ortolani F. et al., 2010; 
paper in preparation). Of interest, increased risk of cardiac dysfunction, with adverse 
outcomes including coronary calcification, has been reported in human observational studies 
on individuals with Pi serum levels just below the upper limit of the conventional 
normophosphatemic range (Tonelli M. et al., 2005; Foley R.N., 2009; van Kuijk J.P. et al., 
2010; Ellam T.J. and Chico T.J., 2012; Osuka S. and Razzaque M.S., 2012). 
Taking in account that there were enhanced mineralizing effects exerted by the additional 
treatment with LPS and medium derived from LPS-stimulated macrophage cultures only for 
AVICs exposed to the highest Pi level, inflammation could be conceivably regarded as an 
effective exacerbating factor in dystrophic calcification for subjects with the highest 
normophosphatemic values at least for the short-term period. Actually, for 2.0-Pi-LPS-bCM-
cultures spectrophotometrically estimated calcium amounts showed to increase linearly 
starting from 21 days of treatment, consistently with the formation of von-Kossa-positive 
intracytoplasmatic PPM and pericellular PPLs clearly appearing as major HA nucleators in 
increasing numbers of mineralizing cells and cell debris. Likely, in the same cultures cell 
mineralization may be sustained by the progressive increase in ALP activity, ensuring the 
continuous production of Pi and concurrent removal of mineralization inhibitor 
pyrophosphate, which could result from direct effects of bacterial LPS on cultured AVICs, as 
previously reported (Babu A.N. et al., 2008; Meng X. et al. 2008; Yang X. et al., 2009). 
However, ALP activity was found drastically to increase during the last three days of 
treatment also for 2.0-Pi-cultures, which were free from bacterial LPS, consistently with the 
idea that the extracellular Pi concentration is the most critical factor for cell mineralization 
(Jono S. et al., 2000; Kirsch T., 2006; Giachelli C.M., 2009). As a matter, interplay seems to 
exist between Pi concentration and ALP activity in such a way that Pi generated by enzymatic 
activity can act as a self-upregulating molecule through a positive feedback mechanism 
thereby sustaining cell mineralization (Kirsch T., 2006). Consistently, absence of calcification 
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resulted for all AVIC cultures containing 0.8 mM Pi as well as 1.3 mM Pi, in which both 
calcium amounts and ALP activities were lower than those estimated for cultures containing 
2.0 mM Pi. Moreover, these two parameters were similar comparing AVIC cultures treated 
with low Pi solely and those stimulated with bacterial LPS and macrophage-derived 
conditioned medium, strengthening the concept that pro-inflammatory mediators require a 
high-Pi-containing milieu to exert pro-calcific effects exacerbating those elicited by Pi. 
Despite the estimated increases in ALP activity, it is noteworthy that, as for metastatic-like 
in vitro calcification, no cell osteoblastic trans-differentiation was observed, being AVICs 
subjected to the calcification process primed by the above described cell-death-associated 
lipid moiety release. In such a context, the CB-reactivity and positivity to von Kossa reaction 
starting from the periphery of the early new-formed lipid droplets correlate with an initial 
lipid acidification (Ortolani F. et al., 2002a; Ortolani F. et al., 2002b) which may depend on 
oxidative effects exerted by endogenous reactive oxygen species (ROS) released by 
degenerating mitochondria (Li X. et al., 2013), with the additional macrophage-derived ROS 
contained in the conditioned medium (Wu T.T. et al., 2009) possibly reinforcing these 
deleterious effects. Such an assumption is supported by the evidence that melting of lipids 
within these droplets and their subsequent release result in the formation of CB-reactive and 
von-Kossa-positive PPM and PPLs, i.e. the major HA nucleator in actual aortic valve 
calcification (Kim K.M. and Huang S.N., 1971; Kim K.M. and Trump B.F., 1975; Kim K.M., 
1976; Kim K.M. et al., 1976) as well as in vivo experimental one (Ortolani F. et al., 2002a; 
Ortolani F. et al., 2002b; Ortolani F. et al., 2003; Ortolani F. et al., 2007).  
Additionally, oxidized phospholipids could result in membrane destabilization leading to 
organelle swelling, as observed for mineralizing cells from 2.0-Pi-LPS-bCM-cultures. Taking 
in account that also lysosomes can be subjected to oxidative-stress-dependent membrane 
permeabilization, it is likely that intracytoplasmatic release of lysosomal acid hydrolases is 
reasonably responsible for the autolytic organelle colliquation occurring in mineralizing cells. 
Moreover, phospholipid disarray affecting membranes of mitochondria and RER might elicit 
intracytoplasmatic calcium leakage from these two calcium storing organules, thereby 
activating intracellular calcium-dependent enzymes, so contributing to the observed 
membrane colliquation. Likewise, increased intracytoplasmatic calcium concentration might 
trigger cytoskeleton disintegration (Smith M.W. et al., 1991) so facilitating plasmamembrane 
blebbing and pinching off of cell-derived products, as observed for mineralizing AVICs from 
2.0-Pi-cultures and, at greater extent, 2.0-Pi-LPS-bCM-cultures after longer incubation times. 
However, the identification of some degenerating cells accumulating CuB-positive lipid 
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droplets and/or PPM also in 1.3-Pi-LPS-bCM-cultures suggests that such a Pi level can be 
permissive at some extent to cell mineralization thus representing a critical threshold for 
augmented risk of this disease in humans, consistently with clinical reports (Tonelli M. et al., 
2005; Foley R.N., 2009; van Kuijk J.P. et al., 2010). 
In order to ascertain if the observed degeneration patterns depend on a sudden unregulated 
cell breakdown or are the final steps of an aborted orthodox type of cell death. Distinct cell 
fates, that is autophagocytosis survival in opposition to death-associated mineralization, were 
found to take place and mainly to depend on Pi concentration, with the added inflammation 
mediators being potential enhancing agents.  
Of note, exposure of cells to oxidative stress was also reported to contribute to RER stress, 
leading to the activation of the signalling pathway called unfolded protein response (UPR) 
(Malhotra J.D. and Kaufman R.J., 2007; Malhotra J.D. et al., 2008). Since the execution of 
UPR requires RER expansion (Schröder M., 2008), it ensues that the abnormal RER 
hypertrophy observed for 0.8- and 1.3-Pi-LPS-bCM-cultures and, to a less extent, 0.8- and 
1.3-Pi-cultures may depend on toxic effects exerted by oxidative stress at low Pi 
concentrations, thereby enabling the activation of transient compensatory mechanisms. 
Consistently, no mineralization took place in the AVIC cultures containing low Pi and 
disappearance of RER hypertrophy was observed for the same cultures once standard culture 
medium was restored. By contrast, the only occasional identification of RER hypertrophy in 
2.0-Pi-cultures and 2.0-Pi-LPS-bCM-cultures suggests that elevated Pi might lead to cell 
death because causing excessive toxication, so compromising the activation of compensatory 
responses by the stressed cells. Being mitochondria especially found to undergo selective 
segregation into the cytoplasmic lacunae delimited by the hypertrophic RER, it is likely that 
sequestration of damaged mitochondria may ensure prompt buffering of increasing 
intracytoplasmatic calcium via its direct uptake by RER, thereby mitigating the deleterious 
effects of calcium overload, consistently with possibility of direct communication between 
RER and mitochondria, as previously reported (de Brito O.M. and Scorrano L., 2008; Giorgi 
C. et al., 2009). Referring to the seemingly unaltered mitochondria entrapped by RER, such 
communications might represent a way to facilitate calcium transfer from RER to 
mitochondria, so implementing their bioenergetic response and improving cell adaptation to 
stressing conditions, as reported for HeLa cell cultures subjected to RER stress (Bravo R. et 
al., 2011). 
Notably, the identification of acid phosphatase activity at level of hypertrophic RER 
membranes as well as its increasing versus controls strongly suggests that an alternative, non-
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lysosomal mechanism of organelle digestion is activated by the treated AVICs, as 
ultracytochemically shown for other cell types (Borgers M. and Thoné F., 1976; Griffiths 
G.W., 1979; Jones G.W. and Bowen I.D., 1979; Noda T. and Farquhar M.G., 1992). Such 
RER degrading activity may somehow represent a time-saving process, providing more rapid 
recovery of homeostatic conditions by stressed cells than activation of orthodox autophagic 
machinery can do, consistently with the apparent scarcity of autophagic vacuoles and the 
decrease in immunoreactivity to autophagosome marker MAP1LC3A observed for 1.3-Pi-
LPS-bCM-cultures.  
On the other hand, excessive autophagic activity has been reported to lead to cell death in 
various cell types (Debnath J. et al., 2005; Levine B. and Yuan J., 2005), including AVICs for 
which associated production of calcium-binding matrix vesicles was reported (Somers P. et 
al., 2006). In the present study, marked immunopositivity to MAP1LC3A restricted to both 3-
day-long control-cultures and 1.3-Pi-LPS-bCM-cultures is consistent with the observed 
ultrastructural features, which are accepted to represent the most reliable parameter to 
recognize this cell response (Klionsky D.J. et al., 2012), so supporting the concept of 
autophagocytosis priming. Since also controls-cultures are included in this process,  an 
autophagy will be present under form of orthodox constitutive house-keeping process 
(Mizushima N., 2005) enabling an adaptive cell response to the culture environment, so 
representing a mere epiphenomenon which can acquire the role of extreme survival 
mechanism by RER overgrowing and associated autolytic activity. Later, this cell response 
might transform from pre-calcific survival process into potentially pro-calcific one once the 
first activity fails, leading to cell death. 
Rather than autophagy-associated cell death, apoptotic cell death is considered to be 
involved in cardiovascular tissue calcification via release of pro-calcific apoptotic bodies by 
dying cells (Lee Y.S. and Chou Y.Y., 1998; Proudfoot D. et al., 2000; Jian B. et al., 2003; 
Clarke M.C.H. et al., 2008). Immunocytochemical data revealed only sporadic immuno-
positivity to late marker annexin-V. Such an assumption was further supported by the finding 
that both 1.3-Pi-LPS-bCM-cultures and 2.0-Pi-LPS-bCM-cultures were lacking in the 17 kDa 
cleaved form of caspase-3, which is an apoptosis executioner. Additionally, absence of 
apoptotic cascade activation in mineralizing AVICs was confirmed by (i) complete absence of 
typical apoptosis features, such as cell shrinkage and chromatin condensation/fragmentation, 
and (ii) occurrence of the described lipid-release-associated pro-calcific cell degeneration also 
in 2.0-Pi-LPS-bCM-cultures after treatment with pancaspase inhibitor BOC-D-FMK. This 
latter result also confirmed a previous finding that another apoptosis inhibitor (Z-VAD-FMK) 
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prevented in vitro cultured sheep AVICs from apoptosis without affecting calcific nodules 
formation (Jian B. et al., 2003). All these data suggested that apoptosis is not involved in 
AVIC degeneration. 
Since no main features characterizing oncosis, such as cell swelling with cytoplasm loss, 
were observed too, an alternative, still unclassified type of cell death could be assumed to take 
place in calcific AVICs, putatively characterized by a distinct regulated process resulting in 
the lipid-releasing-associated cell degeneration which was actually observed in the present 
conditions as well as in others referring to valve calcification (Ortolani F. et al., 2002a; 
Ortolani F. et al., 2002b; Ortolani F. et al., 2003; Ortolani F. et al., 2007; Ortolani F. et al., 
2010; Bonetti A. et al., 2012).  
Raman microspectroscopy and Raman imaging allowed to achieve the identification of 
accumulated lipid moieties as well as their distinct topographical distribution also within 
CAVS-affected aortic valves. The Raman maps achieved specifically correlated with the 
histological pattern, proving that Raman microspectroscopy can represent a reliable technique 
in addiing information on the calcific process underlying this calcific disease. 
In particular, HA maps revealed the highest intensity of mineral there where calcific 
nodules were histologically displayed and minor intense areas corresponded to those 
containing von Kossa reactive particles. Silver staining showed a distribution closely 
correlating with that displayed by the Raman map for HA, except for the zones occupied by 
calcific nodules, in which excessive mineral accumulation masked the underlying/mingled 
material. 
Consistently with in vitro data, Raman microspectroscopy provided the additional 
information that the precipitated material was type B carbonate HA, as inferred from the 
presence of Raman band at 959 cm-1 (Penel G. et al., 1998). This chemical species was 
previously identified as the most abundant form of HA in young bone tissue (Burnell J.M. et 
al., 1980; Rey C. et al., 1989). Although this identification could be consistent with the view 
of valve calcification being a form of heterotopic ossification, it must be stressed that 
effective bone metaplasia was reported but being restricted to less than 13% of hundreds of 
aortic valves and dozens of mitral valves affected by dystrophic calcification (Mohler E.R. 3rd 
et al., 2001; Steiner I. et al., 2007) and no osteogenetic features resulted from the present 
histologic and ultrastructural examinations as well.  
Notably, complete overlapping between reactivity to von Kossa reaction and HA Raman 
map was found to be extended to the map patterns revealing the deposition of 
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phospholipid/triglyceride moieties, whereas those of cholesterol and carotenoids were 
restricted to the areas in which phospholipids/triglycerides showed the highest intensities. 
A first indication supplied by these results is that a direct role in calcification is played by 
phospholipid/triglyceride moieties with restriction to phospholipids because of their ionic 
nature. In addition, the lacking of cholesterol and carotenoids in the areas containing minor 
concentrations of HA leads to exclude that these lipids are essential at least for early 
mineralizing process. Thus calcification priming would have to be restricted to phospholipids 
alone, supporting the concept of these amphiphilic molecules being major HA nucleators 
(Kim K.M. and Huang S.N., 1971; Kim K.M. and Trump B.F., 1975; Kim K.M., 1976; Kim 
K.M. et al., 1976). Consistently with this assumption, the CuB-reacted thin sections showed 
release and accumulation of a material which likely contains abundant phospholipids in that 
(i) it must be anionic, because of their strong affinity for CuB which is a basic phthalocyanin, 
and (ii) it clearly appears in parallel with disappearance of plasmamembranes and organule 
membranes. Interestingly, analogous deposition of CuB-reacting pro-calcific material was 
found to represent one of the degenerative events involving dying AVICs in experimental 
calcification induced using both in vivo (Ortolani F. et al., 2002a; Ortolani F. et al., 2002b; 
Ortolani F. et al., 2003; Ortolani F. et al., 2007) and in vitro models colocalizing with early 
HA crystallization (Ortolani F. et al., 2010; Bonetti A. et al., 2012). 
It is noteworthy that HA deposition at level of calcific nodules was so prominent that the 
underlying chemical components were not detectable at all because of complete masking 
effect. 
With the exception of calcific nuclei, the presence of abundant cholesterol at level of valve 
the other calcific foci  resulted from Raman microspectrometry consistently with the reports 
that cholesterol deposition is a hallmark of CAVS (Otto C.M.et al., 1994; O’Brien K.D. et al., 
1996; Pohle K. et al., 2001) as well as the concept that CAVS is a kind of valve 
atherosclerosis (Agmon Y. et al., 2001; Branch K.R. et al., 2002; Novaro G.M. and Griffin 
B.P., 2003; Kuusisto J. et al., 2005). Additionally, overabundance of phospholipids/ 
triglycerides is not quantitatively reliable to cell degeneration only, suggesting that an 
exogenous uptake of these molecules occurs via LDL endocytosis. This concept is 
strengthened by Raman detection of carotenoids, as discussed below.  
Although the major HA nucleating role is played by phospholipids, it cannot be excluded 
that also cholesterol contained within LDLs might contribute to mineralization once these 
lipoproteins undergo oxidation thereby exerting toxic effects on AVICs and concurrent 
transformation of macrophages into foam cells followed by pro-calcific cell death, as reported 
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to occur for CAVS (Olsson M. et al., 1999; Mohty D. et al., 2008). Consistently, effective 
formation of oxysterols was reported to occur in atherosclerotic lesions (Carpenter K.L. et al., 
1995; Brown A.J. and Jessup W., 1999). 
Additional result gained for the first time was the identification of carotenoids accumulated 
within the calcific areas of CAVS-affected valves, so exhibiting close co-localization with 
cholesterol. Of interest, Raman microspectroscopy already revealed the presence of 
carotenoids, as well as their co-localization with lipid/cholesterol deposits, at level of 
atherosclerotic plaques (Redd D.C. et al., 1991; Baraga J.J. et al., 1992; Römer T.J. et al., 
1998; van de Poll S.W. et al., 2003). This further corroborates the concept of CAVS to 
represent valve atherosclerosis. 
Since it is well known that these lipophilic molecules are mostly transported in the human 
plasma by LDLs in addition to cholesterol and phospholipids (Parker R.S., 1996), it ensues 
that their presence correlates with an uptake of lipoprotein-cholesterol-carotenoid complexes 
by lipid-loading macrophages and/or AVICs via their native LDL-receptors, at the early 
stages of CAVS disease. Subsequently, these complexes could merge with the membrane-
derived phospholipids/cholesterol released during initial cell degeneration and then retained in 
dying cells and cell-derived products.  
Concerning collagen detection with Raman microspectroscopy, its presence generally 
appeared in areas coinciding with those showing eosinophilia in their counterpart on adjacent 
cryosections undergone histological staining and von-Kossa reaction, without allowing a 
discrimination between those still containing collagen fibers and those occupied by unarrayed 
collagen because of fiber dissociation/degeneration (Kaden J.J. et al., 2003). In addition, the 
areas in which Raman maps revealed collagen absence roughly to correspond to those 
completely lacking in eosinophilia in their counterparts. Both results lead to assume ongoing 
collagen degeneration to result in protein denaturation and these areas to represent the most 
aged foci affected by the pro-calcific degenerative processes.  
Electron microscopy pictures of CAVS-affected human valves revealed the presence of 
foam cells and monohydrate cholesterol clefts, consistently with previous findings (Olsson M. 
et al., 1999). It is noteworthy the observation of mixing between neutral lipid formed light 
droplets and acidic lipid containing CuB-reactive droplets, suggesting foam cells to undergo 
analogous pro-calcific degeneration, with the difference that CuB-reactive lipid droplets will 
contain greater moieties of neutral lipids, possibly destined to undergo subsequent 
acidification by oxidative processes. 
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Uptake of subendothelial LDLs and cytosolic accumulation of LDL-derived lipids 
represent a critical step in foam cell formation. Most of the LDL in atherosclerotic plaques is 
aggregated and avidly bound to the subendothelial matrix (Smith E.B. et al., 1976; Tabas I., 
1999; Boren J. et al., 2000). Aggregated lipoproteins require different uptake than those used 
for endocytosis of monomeric lipoproteins, as described below. 
The possible involvement of LDL suggested by the obtained Raman data led to investigate 
possible pro-calcific AVIC responses by combining for the first time pro-calcific models with 
a pro-atherosclerotic model already used to study vascular smooth muscle cells (Llorente-
Cortés V. et al., 1998), which includes the subministration of native low density lipoproteins 
(nLDL) and aggregated ones (agLDL) to the cultured cells.  
Consistently with the identification of specific LDL receptor 5 (Lrp5) reported for AVICs 
(Rajamannan N.M. et al., 2005), effective LDL uptake was directly shown by the 
ultrastructural visualization of intracellular vacuoles containing either nLDL or agLDLs and 
indirectly by the chromatographically detected changes in LDL-related lipid contents, i.e. 
accumulated esterified cholesterol (EC) and triglycerides (TG), these latter resulting from 
intracytoplasmic phospholipid processing and storage.  
Treatments with nLDLs were chromatographically found to result in no or negligible 
increases in intracellular EC and TGs, except for 2.0-Pi-LPS-bCM-nLDL-cultures and 3.0-Pi-
LPS-bCM-nLDL-cultures. 
In contrast, increased amounts of intracellular both CE and TGs were detected after 
treatments with agLDLs. The datum concerning CE agrees with previous finding concerning 
VSMCs (Llorente-Cortés V. et al., 1998) besides being consistent with the ultrastructural 
visualization of many vacuoles containing beaded elongated structures.  
The above different changes in lipid amounts indicate different internalization rates by 
AVICs to exist, comparing nLDLs to agLDLs. These results can be explained taking in 
account that distinct pathways are elicited, since specific Lrp5 is involved for nLDLs and 
LDL-receptor-related-protein-1 (LRP1) for agLDLs, as shown for cultured human VSMCs 
(Llorente-Cortés V. et al., 2000). Additionally, it is noteworthy that opposite cell responses 
are triggered by intracellular cholesterol since it downregulates Lrp5 and upregulates LRP1 
(Llorente-Cortés V. et al., 2002a; 2002b). 
In addition, the constant unchanging of CE content in all nLDL-treated cultures as well as 
its constant marked increase in all agLDL-treated ones, lead to argue that neither Pi 
concentration nor the presence of pro-inflammatory factors can influence AVIC capability to 
uptake LDLs for both cases.  
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The estimations of TGs seem to be not consistent with such a conclusion, since these lipids 
increased in 2.0-Pi-LPS-bCM-nLDL-cultures and 3.0-Pi-LPS-bCM-nLDL-cultures and  there 
was a lesser increase in 3.0-Pi-LPS-bCM-agLDL-cultures compared to the increases 
estimated for agLDL-cultures and 2.0-Pi-LPS-bCM-agLDL-cultures.  
At first glance, these results seem to be inconsistent with the LDL-uptake propensity    
assumed above. However, several speculations could explain these discrepancies. First, TG 
increasing in 2.0-Pi-LPS-bCM-nLDL-cultures and 3.0-Pi-LPS-bCM-nLDL-cultures might 
depend on endogenous mechanisms someway evocated by the pro-inflammatory agents 
involved in the superstimulation, i.e. added LPS and/or cytokines derived from LPS-
stimulated macrophages, which might exert endogenous TG synthesis. As a matter, it was 
found that stimulation with IL-1β increases intracellular TGs in von Kupffer cells and hepatic 
stellate cells (Miura K. et al., 2010). Second thing, the lesser TG increase in 3.0-Pi-LPS-
bCM-agLDL-cultures may be explained by the fact that not all the internalized agLDL-
derived PLs are converted into TGs because of their ongoing degeneration, implying 
diminished activity of the inherent enzymatical machinery, with not converted PLs being 
degraded and contributing to generate the heterogeneously electrondense lipid droplets 
revealed by electron microscopy. 
Spectrophotometric assays revealed that agLDL-treatment resulted in increased calcium 
levels at greater extent and earlier than nLDLs did, i.e. at three day of incubation instead of 
nine. Of note, agLDLs have been reported to represent the main character in the atherogenic 
process (Haka A.S. et al., 2009). 
Moreover, calcium increases provoked by the basical pro-calcific stimulations (2.0-Pi-
LPS-bCM-cultures and 3.0-Pi-LPS-bCM-cultures) were distinctly modified by the addition of 
nLDLs or agLDLs. Namely, significantly higher Ca content resulted after agLDL 
administration, whereas it was significantly lower after nLDL administration.  
Of note, the opposite effect exerted by nLDLs is consistent with several in vivo and in vitro 
findings that nLDLs bind LPS via a mechanism involving apolipoprotein B-100, thus 
neutralizing the effects of this bacterial endotoxin (Van Lenten B.J. et al., 1986; Flegel W.A. 
et al., 1989; Victorov A.V. et al., 1989; Feingold K.R. et al., 1995; Netea M.G. et al., 1996; 
Netea M.G. et al., 1998). Thus the decrease of Ca levels observed in 2.0-Pi-LPS-bCM-nLDL-
cultures and 3.0-Pi-LPS-bCM-nLDL-cultures might be postulated that the potential pro-
calcific effect of LPS was inhibited by binding between endotoxin and lipoprotein. 
Electron microscopy showed that treatments with nLDL solely correlated with features of 
cell suffering as in AVICs cultured at low Pi concentrations, mainly consisting in the 
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described abnormal enlargement of endoplasmic reticulum. These ER-stress patterns can be 
correlated with the finding that oxidized LDLs increase cytosolic calcium concentration in 
cultured porcine AVICs, thereby alterating ER capability to promote protein folding (Cai Z. et 
al., 2013) resulting in the accumulation of unfolded or misfolded proteins (Xu C. et al., 2005; 
Marciniak S.J. and Ron D., 2006; Ron D. and Walter P., 2007). 
Conversely, combination of nLDL treatment with pro-calcific one resulted in no evident 
suffering features at ultrastructural level, indicating a possible anti-calcific role played by 
nLDL, consistently with the above mentioned spectrophotometrical calcium estimations. 
Administration of agLDLs alone was not associated with appearance of evident features of 
cell suffering, suggesting increased calcium levels in AVICs to occur via a different 
mechanism, maybe involving LRP1. This is consistent with the finding that such a receptor 
protein is overexpressed in presence of agLDLs (Llorente-Cortés V. et al., 2002b), thereby 
increasing the number of its cytoplasmic domains, which are characterized by capability to 
retain calcium (Bacskai B.J., et al., 2000; Andersen O.M. et al., 2003). 
Conversely, agLDL combined with Pi, LPS and bCM exacerbated pro-calcific AVIC 
degeneration, culminating in the formation of the same final mineralization products 
described above, i.e. CDPs and calcospherulae.   
 
Taken together, the obtained results lead to the conclusion that in both in vitro metastatic-
like and dystrophic-like conditions as well as in actual CAVS, AVICs calcification (i) 
depends on the described peculiar cell degeneration, being (ii) Pi concentration the major 
determinant, (iii) pro-inflammatory agents potential enhancing factors, and (iv) agLDLs 
additional exacerbating factors. 
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